Disorders of calcium metabolism

E4_CA_MET

calcium metabolic disease: Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Hospital discharge: ICD-9 — 2754 Cause of death: ICD-10 — E83.50, E83.50+F02.89, E83.50+N16.3, E83.51, E83.58, E83.59 Cause of death: ICD-9 — 2754 2 out of 7 registries used, show all original rules.	2627
4. Check minimum number of events None	2627
5. Include endpoints None	2627
6. Filter based on genotype QC (FinnGen only)	2538

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	E4_CA_MET
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E835
HD_ICD_9	2754
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E835
COD_ICD_9	2754
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of calcium metabolism based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2538	1517	1021
Unadjusted period prevalence (%)	0.51	0.54	0.47
Median age at first event (years)	64.63	63.59	66.18

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2627: Matched controls
26270

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

E21.3

ICD-10 Finland

Hyperparathyroidism, unspecified

31.2

307.7

234

106

Kela drug reimbursment

Hypoparathyroidism

167.7

307.7

187

E83.50

ICD-10 Finland

Hypercalcemia

898.8

307.7

1565

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

35.3

307.7

267

E87.6

ICD-10 Finland

Hypokalaemia

28.4

307.7

236

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

34.1

307.7

386

132

E21.0

ICD-10 Finland

Primary hyperparathyroidism

27.3

307.7

373

158

A12AA04

ATC

calcium carbonate; oral

29.9

307.7

247

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

62.7

307.7

250

E83.51

ICD-10 Finland

Hypocalcemia

2028.1

307.7

833

A11CC03

ATC

alfacalcidol; systemic

42.3

307.7

513

150

BAA60

NOMESCO Finland

Total thyroidectomy

20.3

307.7

286

157

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

8.3

298.8

432

609

N17.9

ICD-10 Finland

Acute renal failure, unspecified

11.0

285.5

321

327

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.8

250.5

1453

6422

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

62.6

236.3

131

E86

ICD-10 Finland

Volume depletion

59.1

221.4

124

E89.2

ICD-10 Finland

Postprocedural hypoparathyroidism

2171.6

220.9

211

E83.58

ICD-10 Finland

Idiopathic hypercalciuria

746.7

212.8

207

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

21.0

209.7

160

C03CA01

ATC

furosemide; systemic

3.4

202.0

1168

4988

H05BX01

ATC

cinacalcet; oral

31.2

186.1

122

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

12.9

182.3

180

149

321

Kela drug reimbursment

Paricalcitol and cinacalcet

29.4

181.2

121

N19

ICD-10 Finland

Unspecified kidney failure

8.2

165.6

231

307

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

18.3

165.5

134

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

5.0

164.9

394

893

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

12.0

164.5

170

151

N18.8

ICD-10 Finland

Other chronic renal failure

10.4

161.8

184

188

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.1

161.8

522

1494

JN4AD

NOMESCO Finland

Body CT examination

4.1

158.2

512

1467

E87.5

ICD-10 Finland

Hyperkalaemia

34.7

153.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

5.4

143.2

308

635

E21.2

ICD-10 Finland

Other hyperparathyroidism

35.4

141.2

104

Kela drug reimbursment

Thyroid insufficiency

4.6

140.3

372

913

M04AA01

ATC

allopurinol; systemic

3.6

137.5

545

1783

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.7

137.0

1494

8541

M05BX04

ATC

denosumab; parenteral

4.5

135.8

364

900

N02AA05

ATC

oxycodone; systemic

3.1

133.8

723

2854

TK800

NOMESCO Finland

Hemodialysis

10.9

133.3

146

141

EP1AE

NOMESCO Finland

Neck ultrasound examination

5.0

133.3

315

703

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

14.9

130.2

117

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

126.2

611

2254

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.0

125.3

232

415

Z49.1

ICD-10 Finland

Extracorporeal dialysis

13.4

121.8

116

BB1BQ

NOMESCO Finland

Extensive scintigraphy of parathyroid gland, 2 isotopes, SPECT and low-dose CT

30.5

121.5

H03AA01

ATC

levothyroxine sodium; systemic

2.8

118.2

855

3917

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.3

115.8

529

1877

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

115.1

638

2532

B03XA02

ATC

darbepoetin alfa; parenteral

8.3

109.7

148

188

V03AE01

ATC

polystyrene sulfonate; oral

15.2

109.6

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

17.6

106.1

A11CC02

ATC

dihydrotachysterol; oral

146.2

106.0

112

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

517.4

101.3

100

BBA20

NOMESCO Finland

Exploration of parathyroid gland

41.6

101.0

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

15.8

100.2

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

13.5

99.3

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.3

98.1

270

676

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

97.1

961

5030

WW500

NOMESCO Finland

Blood transfusion

5.0

95.1

215

459

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.0

94.1

491

1865

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

25.0

93.6

D64.9

ICD-10 Finland

Anaemia, unspecified

3.2

89.5

417

1482

AA1AD

NOMESCO Finland

CT of head and brain

2.4

88.9

866

4469

D35.1

ICD-10 Finland

Benign neoplasm: Parathyroid gland

31.2

88.7

Z51.5

ICD-10 Finland

Palliative care

3.4

87.3

346

1113

127

Kela drug reimbursment

Transplant complication

10.6

86.6

KA1AE

NOMESCO Finland

Kidney ultrasound examination

6.3

85.4

148

247

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.9

84.3

472

1856

JN3AD

NOMESCO Finland

Abdominal CT examination

3.0

83.6

419

1549

N17.8

ICD-10 Finland

Other acute renal failure

11.8

82.9

N18.0

ICD-10 Finland

End-stage renal disease

12.4

82.5

Z94.0

ICD-10 Finland

Kidney transplant status

12.6

82.4

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

21.5

81.5

Z49.0

ICD-10 Finland

Preparatory care for dialysis

12.9

80.5

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

24.3

79.9

C90.0

ICD-10 Finland

Multiple myeloma

9.5

79.9

105

E83.59

ICD-10 Finland

Other disorders of calcium metabolism

802.1

79.8

XW000

NOMESCO Finland

Bone marrow biopsy

4.5

79.7

203

477

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.6

79.7

155

289

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.4

79.3

723

3594

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

9.5

77.8

101

L04AD02

ATC

tacrolimus; systemic

14.6

77.7

L04AA06

ATC

mycophenolic acid; systemic

8.3

77.5

103

128

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

14.7

76.9

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

8.9

76.5

111

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

9.0

76.2

109

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

74.9

674

3320

SPAT1262

SPAT

Handing over of treatment supplies

2.5

74.1

564

2573

R53

ICD-10 Finland

Malaise and fatigue

2.3

73.8

712

3613

A02BC02

ATC

pantoprazole; systemic

2.3

73.7

1908

14200

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.3

72.2

766

4040

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

5.5

71.2

141

267

137

Kela drug reimbursment

Uraemia requiring dialysis

12.9

71.0

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.4

70.9

187

451

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.0

70.6

350

1280

J01MA12

ATC

levofloxacin; systemic

2.4

70.4

608

2931

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

70.1

1071

6498

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.1

69.5

204

533

196

Kela drug reimbursment

Paricalcitol and cinacalcet

19.7

69.5

H02AB06

ATC

prednisolone; systemic

2.0

69.4

1370

9119

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

4.5

68.6

176

415

WZC30

NOMESCO Finland

Teaching

2.5

68.5

537

2475

153

Kela drug reimbursment

Lenalidomid

13.4

67.5

A10AB05

ATC

insulin aspart; parenteral

3.4

67.0

260

821

ZX120

NOMESCO Finland

Intravenous

3.0

66.4

336

1241

H03BB01

ATC

carbimazole; oral

4.5

65.9

168

394

R50.9

ICD-10 Finland

Fever, unspecified

2.5

65.8

487

2183

3025

Kela drug reimbursment

Calcium carbonate

23.9

65.5

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

8.5

65.3

103

L04AX04

ATC

lenalidomide; oral

12.9

65.0

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.6

64.3

158

360

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

19.6

64.2

V03AE02

ATC

sevelamer; oral

16.9

63.5

C08CA01

ATC

amlodipine; oral

2.0

63.5

1109

6999

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

63.2

704

3756

A41.9

ICD-10 Finland

Sepsis, unspecified

4.5

62.8

159

371

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

9.8

62.0

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

12.5

61.7

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.8

61.6

347

1355

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.2

61.4

666

3510

V03AE03

ATC

lanthanum carbonate; oral

23.5

61.0

B05DB

ATC

Hypertonic solutions

15.4

60.6

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

10.1

59.7

A10AE04

ATC

insulin glargine; parenteral

3.0

59.0

290

1051

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

9.1

58.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

5.3

58.3

120

235

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

13.8

57.1

E20.9

ICD-10 Finland

Hypoparathyroidism, unspecified

105.8

57.1

TPH07

NOMESCO Finland

Cathetrisation of artery

2.7

56.7

346

1406

205

Kela drug reimbursment

Chronic hypertension

2.0

56.6

786

4530

TK810

NOMESCO Finland

Hemofiltration

18.3

56.0

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.0

55.8

166

437

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

6.6

55.1

141

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

5.2

55.0

116

232

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.8

54.9

310

1209

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

5.1

54.9

118

240

I50.9

ICD-10 Finland

Heart failure, unspecified

2.5

54.5

411

1847

329

Kela drug reimbursment

Lenalidomide

13.8

53.7

E20.8

ICD-10 Finland

Other hypoparathyroidism

+∞

53.3

Z49.2

ICD-10 Finland

Other dialysis

12.0

53.3

B05DA

ATC

Isotonic solutions

12.3

53.1

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

15.6

52.9

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.3

52.8

142

347

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.7

52.7

178

512

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

8.2

52.6

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

52.1

739

4271

C07AB07

ATC

bisoprolol; oral

1.9

51.9

1316

9204

R11

ICD-10 Finland

Nausea and vomiting

2.8

51.6

273

1028

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.1

51.4

656

3648

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

10.6

50.9

N02AX02

ATC

tramadol; systemic, rectal

1.9

50.5

1179

8015

N16.3*E83.50

ICD-10 Finland

Nefrocalcinosis NEC

260.3

50.2

M10.9

ICD-10 Finland

Gout, unspecified

3.1

50.0

223

763

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.7

49.8

298

1196

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.1

49.7

107

218

D86.0

ICD-10 Finland

Sarcoidosis of lung

7.8

49.3

SPAT1254

SPAT

Administration of medicine

2.3

48.7

447

2180

KH1AD

NOMESCO Finland

CT of urinary organs

4.1

48.2

138

353

ZXD05

NOMESCO Finland

Urgent procedure

1.9

47.9

803

4892

103

Kela drug reimbursment

Diabetes, insulin-treated

2.0

47.7

709

4145

B01AB10

ATC

tinzaparin; parenteral

2.5

47.7

331

1426

WW200

NOMESCO Finland

Immunization

4.8

47.1

108

232

A04AA01

ATC

ondansetron; systemic, rectal

2.7

46.5

282

1137

H02AB09

ATC

hydrocortisone; systemic

5.1

46.4

100

204

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

14.9

46.0

L28

ICPC

Limited function/disability (L)

2.1

45.8

526

2799

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.3

45.5

183

588

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.7

45.4

152

434

A06AD11

ATC

lactulose; oral

2.2

45.3

445

2226

E21.1

ICD-10 Finland

Secondary hyperparathyroidism, not elsewhere classified

74.4

45.1

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

44.8

1598

12174

JN4BD

NOMESCO Finland

Extensive body CT

2.4

44.8

346

1564

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

44.6

474

2445

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

12.4

44.5

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

4.6

43.8

105

234

E55.9

ICD-10 Finland

Vitamin D deficiency, unspecified

10.9

43.6

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

43.5

633

3657

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

14.6

43.4

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

43.3

360

1678

N02BE01

ATC

paracetamol; systemic, rectal

2.4

43.0

2352

20479

H02AB02

ATC

dexamethasone; systemic

2.3

43.0

382

1832

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

42.6

1097

7565

B03XA01

ATC

erythropoietin; parenteral

9.1

42.5

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.4

42.3

108

253

N20.0

ICD-10 Finland

Calculus of kidney

4.8

42.2

205

A12AA06

ATC

calcium lactate gluconate; oral

69.7

42.1

R06.0

ICD-10 Finland

Dyspnoea

1.9

41.7

726

4441

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.4

41.7

157

484

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.2

41.6

114

282

A10BH05

ATC

linagliptin; oral

3.3

41.3

166

533

ZX108

NOMESCO Finland

Inhalation

10.0

41.0

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

5.5

40.8

150

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.9

40.7

198

710

N03AX16

ATC

[U] pregabalin

1.9

40.1

636

3770

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.3

39.8

320

1468

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

39.6

481

2600

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.0

39.1

186

659

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

5.7

39.0

131

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

39.0

412

2113

J01MA02

ATC

ciprofloxacin; systemic

1.7

38.8

1025

7068

C10AA05

ATC

atorvastatin; oral

1.7

38.4

1017

7014

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

38.4

917

6143

A10AC01

ATC

insulin (human); parenteral

2.7

38.0

217

847

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

38.0

396

2019

UJF32

NOMESCO Finland

Coloscopy

1.8

37.3

724

4557

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.5

37.0

253

1078

C02AC05

ATC

moxonidine; oral

3.2

37.0

151

489

WX402

NOMESCO Finland

General anaesthesia

1.9

36.9

556

3228

212

Kela drug reimbursment

Gout

5.2

36.8

153

M81.9

ICD-10 Finland

Osteoporosis, unspecified

3.0

36.8

172

603

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

8.2

36.7

UKC02

NOMESCO Finland

Cystoscopy

2.0

36.1

451

2454

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.9

36.1

167

U14

ICPC

Kidney symptom/complaint

5.5

36.0

130

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

36.0

439

2370

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

13.2

35.7

GD1AD

NOMESCO Finland

Thorax CT examination

2.8

35.6

192

727

2754A

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCAEMIA]

+∞

35.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

4.1

35.2

250

J01DB01

ATC

cefalexin; oral

1.9

35.1

2119

18105

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

35.0

232

974

B01AB05

ATC

enoxaparin; parenteral

1.7

34.7

847

5675

XX3DW

NOMESCO Finland

Time consuming IT work

2.1

34.2

346

1739

N20.1

ICD-10 Finland

Calculus of ureter

3.3

34.0

129

399

C08CA13

ATC

lercanidipine; oral

2.0

33.9

408

2188

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.1

33.7

148

500

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

33.7

424

2309

M05BA04

ATC

alendronic acid; oral

2.2

33.7

303

1453

T90

ICPC

Diabetes non-insulin dependent

1.8

33.7

603

3687

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.9

33.6

463

2602

WW300

NOMESCO Finland

Transfer of autologic stem cells

12.9

33.2

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

7.6

33.1

SPAT1229

SPAT

Assessment of need for aid

2.4

32.8

243

1073

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.8

32.7

100

268

BBA70

NOMESCO Finland

Implantation or transplantation of parathyroid gland

49.4

32.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

32.4

177

675

KAT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of pelvis of kidney

6.5

32.0

N20.9

ICD-10 Finland

Urinary calculus, unspecified

4.0

31.9

232

XF600

NOMESCO Finland

Bloodpressure measurement

2.7

31.9

177

680

E05.2

ICD-10 Finland

Thyrotoxicosis with toxic multinodular goitre

5.7

31.8

105

WX892

NOMESCO Finland

Monitored bed care

2.5

31.7

207

862

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

31.5

231

1015

SPAT1263

SPAT

Sampling

1.6

31.4

1068

7752

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

31.4

286

1377

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

7.3

31.4

C03DA01

ATC

spironolactone; oral

2.1

31.4

320

1611

C03AA03

ATC

hydrochlorothiazide; oral

2.2

31.1

270

1275

C10AA01

ATC

simvastatin; oral

1.6

30.8

996

7130

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

12.1

30.8

ZX114

NOMESCO Finland

Intramuscular

5.5

30.6

109

A04

ICPC

Weakness/tiredness general

2.0

30.5

388

2117

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.7

30.4

173

673

TK820

NOMESCO Finland

Peritoneal dialysis

11.6

30.1

130

Kela drug reimbursment

Malignant tumour

2.2

30.0

272

1306

E83.39

ICD-10 Finland

Other disorder of phosphorus metabolism

305.8

29.9

SPAT1216

SPAT

Assessment of functional ability

1.9

29.8

443

2544

E61.2

ICD-10 Finland

Magnesium deficiency

83.6

29.8

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.9

29.7

145

520

A06AH03

ATC

naloxegol; oral

5.0

29.6

131

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

29.3

404

2263

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

6.9

29.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

10.1

29.2

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

29.0

690

4549

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

28.9

144

522

E20.0

ICD-10 Finland

Idiopathic hypoparathyroidism

66.7

28.9

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

9.6

28.9

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.6

28.8

175

703

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

28.8

210

919

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.9

28.7

223

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

6.6

28.6

A10AE05

ATC

insulin detemir; parenteral

2.8

28.4

147

544

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

3.9

28.4

220

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.9

28.3

133

467

A28

ICPC

Limited function/disability NOS

1.9

28.3

449

2630

N05BA04

ATC

oxazepam; oral

1.7

28.2

670

4412

B03BA03

ATC

hydroxocobalamin; parenteral

2.6

28.0

175

713

E21

ICD-10 Finland

Hyperparathyroidism and other disorders of parathyroid gland

27.5

28.0

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

4.5

27.9

158

B01AC04

ATC

clopidogrel; oral

2.0

27.8

357

1951

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

9.8

27.7

E87.2

ICD-10 Finland

Acidosis

146.6

27.7

C07AB02

ATC

metoprolol; systemic

1.8

27.5

518

3194

R4190

NOMESCO Finland

Nutritional therapy

3.2

27.3

113

369

SPAT1255

SPAT

Intravenous administration of medicine

2.4

27.2

203

898

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.8

27.1

232

JN6AD

NOMESCO Finland

CT of torso and neck

4.3

27.1

166

N05CF01

ATC

zopiclone; oral

1.6

27.0

830

5823

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.4

27.0

295

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.4

27.0

158

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

26.9

906

6497

Z3231

NOMESCO Finland

Registered nurse

1.7

26.9

679

4533

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

26.9

339

1839

N16.2*D86.8

ICD-10 Finland

Renal tubulo-interstitial disorders in sarcoidosis

273.8

26.8

A46

ICD-10 Finland

Erysipelas

1.9

26.8

375

2108

KBV00

NOMESCO Finland

Insertion of stent into ureter

8.6

26.7

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

26.6

111

364

ZX112

NOMESCO Finland

Subcutaneous

3.8

26.4

218

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

4.4

26.2

149

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

26.0

26.2

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

23.4

26.1

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.7

26.0

K92.1

ICD-10 Finland

Melaena

2.6

25.8

155

619

A10BA02

ATC

metformin; oral

1.7

25.8

672

4517

E83.5

ICD-10 Finland

Disorders of calcium metabolism

263.1

25.7

L03AA02

ATC

filgrastim; parenteral

3.1

25.6

109

362

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

25.5

790

5537

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

25.5

136

512

N03AX12

ATC

[U] gabapentin; oral

1.8

25.3

427

2542

TGC00

NOMESCO Finland

Bronchial lavation

3.5

25.1

254

BBA50

NOMESCO Finland

Total parathyroidectomy

58.6

25.0

A02BC05

ATC

esomeprazole; systemic

1.6

24.9

1007

7502

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

24.8

491

3061

J01FF01

ATC

clindamycin; systemic

1.6

24.8

673

4563

C09AA02

ATC

enalapril; systemic

1.7

24.6

497

3116

A41.8

ICD-10 Finland

Other specified sepsis

4.1

24.5

166

I50.0

ICD-10 Finland

Congestive heart failure

2.3

24.5

189

848

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

4.7

24.3

121

WX882

NOMESCO Finland

High dependency care

3.4

24.2

275

E21.5

ICD-10 Finland

Disorder of parathyroid gland, unspecified

29.4

24.1

K08.3

ICD-10 Finland

Retained dental root

2.2

24.0

209

985

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.9

23.9

111

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

3.6

23.7

225

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

31.3

23.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

23.6

216

1039

J01MA14

ATC

moxifloxacin; systemic

2.1

23.6

243

1224

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

23.5

454

2807

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

23.4

366

2125

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.5

23.4

151

625

C07AG02

ATC

carvedilol; oral

2.4

23.3

163

700

A02BC01

ATC

omeprazole; systemic

1.6

23.3

690

4769

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

8.4

23.1

L04AX01

ATC

azathioprine; systemic

2.7

23.1

124

468

A10BB12

ATC

glimepiride; oral

2.3

23.1

179

804

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

3.0

23.0

105

363

A04AA02

ATC

granisetron; systemic, transdermal

2.2

22.9

196

918

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.8

22.9

116

425

H02AB04

ATC

methylprednisolone; systemic

1.8

22.7

378

2236

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

22.6

204

976

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

22.6

1056

8070

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

22.5

190

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.3

22.5

184

845

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.1

22.5

150

S97

ICPC

Chronic ulcer skin

2.4

22.5

166

730

A07AA09

ATC

vancomycin; oral

4.8

22.2

106

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

22.1

276

1489

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.3

22.1

131

A12BA01

ATC

potassium chloride; oral

2.6

22.0

128

503

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

22.0

222

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

4.7

22.0

111

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.2

21.9

ZXE20

NOMESCO Finland

More than three and less than five hours

1.8

21.9

337

1946

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.7

21.8

416

2558

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

21.8

547

3619

G72.8

ICD-10 Finland

Other specified myopathies

4.5

21.8

120

N06AX11

ATC

mirtazapine; oral

1.5

21.6

815

5932

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

6.9

21.6

KAE12

NOMESCO Finland

Retrograde ureteronephroscopic lithotripsy in pelvis of kidney

7.5

21.6

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.4

21.6

244

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

21.5

328

1888

SPAT1234

SPAT

Support of social functional capacity

2.4

21.4

148

632

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.9

21.3

161

197

Kela drug reimbursment

Sunitinib

9.0

21.2

WX730

NOMESCO Finland

Conventional respirator

4.7

21.0

103

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.3

21.0

170

778

L95

ICPC

Osteoporosis

2.5

20.9

129

522

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

20.9

278

1531

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.9

20.9

339

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

20.9

216

1089

N30.0

ICD-10 Finland

Acute cystitis

1.7

20.8

400

2464

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

7.4

20.8

ZXA10

NOMESCO Finland

Bilateral

1.7

20.7

472

3043

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.1

20.7

N06AX16

ATC

venlafaxine; oral

1.8

20.7

329

1916

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

20.7

994

7600

132

Kela drug reimbursment

Sarcoidosis

6.2

20.7

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

211.6

20.6

WF004

NOMESCO Finland

Palliative radiotherapy

3.3

20.5

247

H02AB07

ATC

prednisone; oral

1.8

20.5

354

2113

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

20.5

446

2841

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

22.5

20.4

AA1AA

NOMESCO Finland

Head X-ray examination

5.3

20.1

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.3

20.1

235

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

4.3

20.0

124

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

19.9

136

577

L04AD01

ATC

ciclosporin; systemic

3.8

19.9

164

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

19.9

127

522

R4110

NOMESCO Finland

Physiotherapy

1.6

19.8

650

4574

SPAT1310

SPAT

Counselling related to known health issue

1.5

19.7

783

5742

H3603, E103,

ICD-10 Finland

8.2

19.6

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

3.1

19.6

270

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

19.5

676

4810

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

19.5

220

1145

RD210, ,

NOMESCO Finland

4.0

19.3

136

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.4

19.3

206

E66.8

ICD-10 Finland

Other obesity

2.5

19.3

122

500

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

19.3

246

1335

SPAT1172

SPAT

Guidance concerning hydration

3.4

19.2

212

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

26.2

19.1

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.1

19.1

196

985

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

18.9

1059

8305

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.2

18.8

169

806

R33

ICD-10 Finland

Retention of urine

2.1

18.8

190

949

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

18.8

208

1075

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

18.6

224

1191

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

18.6

211

1100

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

4.9

18.5

AN1

Coronary angiography

1.9

18.4

227

1217

C08CA02

ATC

felodipine; oral

1.9

18.3

240

1315

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

7.5

18.2

M81.8

ICD-10 Finland

Other osteoporosis

4.7

18.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

18.2

174

851

SPAT1167

SPAT

Insertion of urinary catheter

2.9

18.2

304

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

18.0

370

2314

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

18.0

1699

14629

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

4.5

18.0

100

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

18.0

440

2880

K65.0

ICD-10 Finland

Acute peritonitis

4.6

18.0

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.1

17.8

122

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

17.8

491

3309

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

20.2

17.7

P01AB01

ATC

metronidazole; oral, rectal

1.5

17.7

942

7289

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

17.6

189

965

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.8

17.5

R31

ICD-10 Finland

Unspecified haematuria

1.9

17.5

245

1369

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

17.5

123

529

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.2

17.4

225

R60.0

ICD-10 Finland

Localized oedema

1.8

17.4

293

1733

KA3EB

NOMESCO Finland

Antegrade pyelography

7.4

17.4

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

7.4

17.4

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

17.3

641

4613

SPAT1301

SPAT

No procedures

1.5

17.2

761

5673

TKC20

NOMESCO Finland

Catheterisation of bladder

2.1

17.2

167

821

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

17.2

167

821

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.4

17.2

121

521

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.5

17.1

105

424

WX002

NOMESCO Finland

Sedation and analgesia

1.6

17.1

470

3162

A10BH01

ATC

sitagliptin; oral

1.9

17.1

222

1211

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

3.8

17.1

135

KBE12

NOMESCO Finland

Transluminal endoscopic extraction of calculus of ureter

4.4

17.1

B81

ICPC

Anaemia vit B12/folate deficiency

2.5

17.1

104

419

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.4

17.0

120

517

R13

ICD-10 Finland

Dysphagia

2.0

17.0

184

942

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

17.0

139

639

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.7

16.9

356

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

4.3

16.9

101

WX872

NOMESCO Finland

Intensive care

2.4

16.8

117

501

N18

ICD-10 Finland

Chronic kidney disease

4.5

16.8

H02AA02

ATC

fludrocortisone; oral

5.7

16.8

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

4.1

16.8

110

KBV10

NOMESCO Finland

Removal of stent from ureter

5.1

16.7

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.8

16.6

302

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.5

1209

9876

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

2.6

16.5

378

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

16.5

143

673

E0000UV, ,

ATC

1.4

16.4

980

7718

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

20.2

16.4

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

16.4

211

1148

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

16.4

297

1794

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.9

16.3

126

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.2

16.2

132

605

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

16.2

242

1379

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

6.6

16.2

F05.9

ICD-10 Finland

Delirium, unspecified

3.4

16.2

169

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

16.2

290

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

30.2

16.1

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

16.1

320

1983

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.2

16.0

195

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.6

16.0

146

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.4

16.0

175

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.0

16.0

184

963

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

21.1

16.0

C09CA01

ATC

losartan; oral

1.5

15.9

626

4548

M13.9

ICD-10 Finland

Arthritis, unspecified

2.0

15.9

179

930

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

15.9

249

1441

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.7

15.9

133

ZXE00

NOMESCO Finland

One hour or less

1.4

15.9

898

6995

C01DA14

ATC

isosorbide mononitrate; oral

1.7

15.8

310

1914

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

3.4

15.7

172

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

15.7

200

1083

105

Kela drug reimbursment

Adrenal cortical hypofunction

33.6

15.7

192

Kela drug reimbursment

Fulvestrant

5.5

15.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

15.7

182

955

NHQ40

NOMESCO Finland

Amputation of toe

4.1

15.7

107

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

15.6

134

628

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

15.6

323

2023

M10.0

ICD-10 Finland

Idiopathic gout

2.7

15.4

326

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.8

15.4

SPAT1211

SPAT

Application of soft bandage

1.8

15.4

225

1275

SPAT1260

SPAT

Consultation of another employee

1.6

15.4

424

2850

C10AA04

ATC

fluvastatin; oral

1.9

15.3

184

977

G47.3

ICD-10 Finland

Sleep apnoea

1.5

15.3

491

3413

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.0

15.3

109

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

15.3

491

3415

N05AH04

ATC

quetiapine; oral

1.6

15.2

379

2486

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

15.2

930

7332

EP1DS

NOMESCO Finland

PET-MRI of neck metabolism

28.8

15.2

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

15.2

272

L03AA13

ATC

pegfilgrastim; parenteral

2.2

15.1

125

577

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.3

15.1

C08DB01

ATC

diltiazem; oral

2.2

15.1

133

630

N20.2

ICD-10 Finland

Calculus of kidney with calculus of ureter

5.8

14.9

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

5.8

14.9

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.2

14.9

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.6

14.8

356

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

14.8

164

A10AD05

ATC

insulin aspart; parenteral

3.6

14.8

135

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

14.8

387

A01

ICPC

Pain general/multiple sites

1.8

14.7

218

1239

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.1

14.7

142

697

XKD00

NOMESCO Finland

Uroflowmetry

1.6

14.7

363

2374

M81.5

ICD-10 Finland

Idiopathic osteoporosis

4.6

14.7

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.4

14.7

155

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

14.6

405

2724

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

6.4

14.6

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.8

14.5

267

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

3.2

14.5

176

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

14.5

885

6959

M54.5

ICD-10 Finland

Low back pain

1.4

14.5

806

6235

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.6

14.5

132

WX202

NOMESCO Finland

Supraclavicular plexus blockade

3.6

14.5

132

R55

ICD-10 Finland

Syncope and collapse

1.8

14.5

248

1473

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.4

693

5221

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

14.3

703

5318

SPAT1097

SPAT

Recording of ECG

1.6

14.3

347

2261

A07AA02

ATC

nystatin; oral

2.0

14.2

156

803

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.4

14.1

101

439

B01AF02

ATC

apixaban; oral

1.7

14.0

291

1821

3AC01, ,

NOMESCO Finland

4.7

14.0

UJF92

NOMESCO Finland

Capsular endoscopy

3.0

14.0

201

A02BC03

ATC

lansoprazole; oral

1.4

14.0

681

5138

L04AA01

ATC

[U] ciclosporin

3.6

14.0

126

E89.09

ICD-10 Finland

Postprocedural hypothyroidism, other or several procedures

53.6

13.8

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.1

13.8

187

C09AA05

ATC

ramipril; oral

1.5

13.7

555

4038

N06AX21

ATC

duloxetine; oral

1.7

13.7

260

1587

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.9

13.7

214

JN4CD

NOMESCO Finland

Very extensive body CT

2.3

13.7

104

464

N06AB04

ATC

citalopram; systemic

1.5

13.6

471

3319

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

13.6

101

446

E20.1

ICD-10 Finland

Pseudohypoparathyroidism

+∞

13.5

E83.9

ICD-10 Finland

Disorder of mineral metabolism, unspecified

+∞

13.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

4.1

13.5

Z2446

NOMESCO Finland

Social worker

2.0

13.5

151

782

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

13.5

130

638

A10AE06

ATC

insulin degludec; parenteral

2.7

13.5

278

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

13.5

142

721

C75.0

ICD-10 Finland

Malignant neoplasm: Parathyroid gland

140.7

13.5

ZXA05

NOMESCO Finland

Left side

1.5

13.4

571

4194

N03AX09

ATC

lamotrigine; oral

2.3

13.4

436

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

4.0

13.4

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.5

13.3

321

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

13.3

108

496

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

13.2

422

2923

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

13.2

338

2227

ZYC01

NOMESCO Finland

Remote contact by phone

2.1

13.2

134

671

K92.0

ICD-10 Finland

Haematemesis

2.8

13.2

230

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

13.2

377

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

13.2

244

1481

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.3

13.1

103

466

394

Kela drug reimbursment

Palbociclib

5.0

13.1

1501

Kela drug reimbursment

Palbociclib

4.8

13.1

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

5.5

13.1

N06AB10

ATC

escitalopram; oral

1.5

13.1

416

2880

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

5.9

13.1

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.5

13.0

318

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

13.0

426

2966

M10.3

ICD-10 Finland

Gout due to impairment of renal function

11.0

13.0

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

9.4

13.0

N11.8

ICD-10 Finland

Other chronic tubulo-interstitial nephritis

28.5

13.0

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.2

12.9

XPX08

NOMESCO Finland

Intraoperative flow measurement

5.0

12.9

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.9

12.9

200

M79.6

ICD-10 Finland

Pain in limb

1.4

12.9

954

7711

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

12.8

403

2780

N03AX14

ATC

levetiracetam; systemic

2.7

12.8

256

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

12.8

218

1291

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

12.8

106

491

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

14.1

12.7

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

3.3

12.7

149

R52.9

ICD-10 Finland

Pain, unspecified

1.7

12.7

218

1296

A10BH02

ATC

vildagliptin; oral

3.2

12.6

160

B99

ICD-10 Finland

Other and unspecified infectious diseases

3.0

12.6

181

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

15.5

12.6

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.6

12.6

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.1

12.5

171

E31.00

ICD-10 Finland

APECED syndrome

+∞

12.5

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.7

12.5

237

R80

ICD-10 Finland

Isolated proteinuria

5.0

12.4

XF402

NOMESCO Finland

ECG with work load test

1.7

12.4

217

1296

SPAT1104

SPAT

Monitoring of emergency patient

1.9

12.4

159

864

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

4.7

12.4

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.4

12.3

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.4

12.3

377

GD1UN

NOMESCO Finland

Lung circulation SPECT

5.8

12.3

Z71.8

ICD-10 Finland

Other specified counselling

1.4

12.2

648

4945

R42

ICD-10 Finland

Dizziness and giddiness

1.5

12.2

510

3726

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

12.2

438

3106

L02BA03

ATC

fulvestrant; parenteral

4.3

12.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

12.2

157

855

5BA08, ,

NOMESCO Finland

5.5

12.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

12.0

166

923

D44.8

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pluriglandular involvement

26.8

12.0

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

12.0

484

3510

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.9

12.0

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.6

12.0

110

SPAT1325

SPAT

Vaccination

1.4

12.0

799

6334

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

11.9

148

795

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.7

11.9

101

M10

ICD-10 Finland

Gout

2.2

11.9

101

472

J94.8

ICD-10 Finland

Other specified pleural conditions

3.2

11.9

145

SPAT1240

SPAT

Therapeutic discussion

1.7

11.9

206

1226

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

11.9

125

634

R06AE07

ATC

cetirizine; oral

1.4

11.8

987

8097

T99

ICPC

Endocr/metab/nutrit disease other

3.2

11.8

141

L01XE04

ATC

[U] sunitinib

14.7

11.8

1502

Kela drug reimbursment

Cabozantinib

14.7

11.8

3012

Kela drug reimbursment

Cabozantinib

14.7

11.8

N07BB01

ATC

disulfiram; oral

2.3

11.8

384

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

11.8

600

4544

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

4.3

11.7

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.7

11.7

234

160

Kela drug reimbursment

exenatide

3.1

11.7

152

T89

ICPC

Diabetes insulin dependent

2.4

11.7

348

V03AG01

ATC

sodium cellulose phosphate; systemic

30.2

11.6

B01AA03

ATC

warfarin; systemic

1.5

11.6

417

2954

WVA20

NOMESCO Finland

Medicine administration

2.7

11.6

229

BB1AN

NOMESCO Finland

Parathyroid gland isotope imaging, 1 isotope

65.2

11.6

2522

FHL

Removal of parathyroidism or multiple parathyroidism (including removal of adenoma or total removal)

23.0

11.6

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

11.5

133

698

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

11.5

446

2754B

ICD-9 Finland

Disorders of mineral metabolism, Disorders of calcium metabolism[HYPERCALCURIA]

+∞

11.5

C09BA02

ATC

enalapril and diuretics; systemic

1.8

11.5

186

1087

C08CA05

ATC

nifedipine; systemic

1.9

11.4

140

749

R52.2

ICD-10 Finland

Other chronic pain

2.3

11.4

389

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

11.4

129

672

SPAT1252

SPAT

Overall medication plan or its review

1.8

11.4

160

896

L17

ICPC

Foot/toe symptom/complaint

1.4

11.3

640

4928

ZXA00

NOMESCO Finland

Right side

1.4

11.3

608

4641

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

11.3

378

C09CA03

ATC

valsartan; oral

1.7

11.3

212

1290

B80

ICPC

Iron deficiency anaemia

2.7

11.2

216

L01CA04

ATC

vinorelbine; systemic

3.7

11.2

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.0

11.2

119

606

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.3

11.2

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

11.2

173

996

R02

ICPC

Shortness of breath/dyspnoea

1.6

11.2

285

1873

JAH00

NOMESCO Finland

Laparotomy

2.4

11.2

311

A12AA12

ATC

[U] calcium acetate

17.1

11.2

J01CA08

ATC

pivmecillinam; oral

1.3

11.2

934

7648

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

4.6

11.2

I50

ICD-10 Finland

Heart failure

2.5

11.2

287

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.6

11.1

240

R79.0

ICD-10 Finland

Abnormal level of blood mineral

20.1

11.1

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

11.1

294

Z3226

NOMESCO Finland

Physiotherapist

1.5

11.1

391

2759

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.3

11.1

121

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

11.1

228

1422

N02BF02

ATC

pregabalin; oral

1.9

11.1

131

693

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.2

11.1

414

A10AB01

ATC

insulin (human); parenteral

2.5

11.0

265

F10.24

ICD-10 Finland

Alcohol depence active use

3.5

11.0

107

N05AN01

ATC

lithium; oral

2.7

10.9

219

J01EA01

ATC

trimethoprim; systemic

1.4

10.9

602

4616

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

10.8

195

1174

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.2

10.8

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

4.2

10.8

A10AB04

ATC

insulin lispro; parenteral

2.6

10.8

232

N05BA06

ATC

lorazepam; systemic, sublingual

2.0

10.8

122

636

J01CF05

ATC

flucloxacillin; systemic

1.9

10.8

132

707

WX704

NOMESCO Finland

Intubation

1.8

10.8

174

1016

R20.2

ICD-10 Finland

Paraesthesia of skin

1.8

10.8

148

823

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.8

10.7

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

10.7

311

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.7

261

1697

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.4

10.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

10.7

400

2520A

ICD-9 Finland

Disorders of parathyroid gland, Hyperparathyroidism

28.1

10.7

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

17.9

10.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

3.7

10.7

C10AB05

ATC

fenofibrate; oral

3.4

10.7

114

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

21.5

10.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.9

10.7

166

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.1

10.6

140

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.0

10.6

117

605

N05BA01

ATC

diazepam; systemic, rectal

1.6

10.6

290

1939

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

11.2

10.5

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.7

10.5

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

10.5

339

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.1

10.5

103

510

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.1

10.5

463

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.6

10.5

M48.0

ICD-10 Finland

Spinal stenosis

1.6

10.5

289

1935

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

10.4

237

1516

KAC10

NOMESCO Finland

Total nephrectomy with capsule

4.1

10.4

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.0

10.4

109

554

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.6

10.4

D64.8

ICD-10 Finland

Other specified anaemias

2.9

10.4

158

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.8

10.3

157

900

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

10.3

311

2122

J01CA04

ATC

amoxicillin; systemic

1.4

10.3

1938

17726

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

4.0

10.3

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

4.3

10.3

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

10.3

126

675

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

10.3

238

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

10.3

167

977

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

4.4

10.3

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.6

10.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

10.2

146

822

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

10.2

126

678

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

10.2

338

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

10.1

371

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

10.1

177

1058

1507

Kela drug reimbursment

Pomalidomide

11.3

10.0

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.4

10.0

271

S76

ICPC

Skin infection other

1.9

10.0

121

645

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

10.0

280

1879

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.0

1034

8690

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

9.2

10.0

R10.0

ICD-10 Finland

Acute abdomen

2.3

10.0

315

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.3

10.0

309

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

10.0

384

2755

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.9

591

4576

JFB00

NOMESCO Finland

Partial resection of small intestine

3.1

9.9

135

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

9.9

267

M80.5

ICD-10 Finland

Idiopathic osteoporosis with pathological fracture

5.2

9.8

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

9.8

131

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.9

9.8

N11.9

ICD-10 Finland

Chronic tubulo-interstitial nephritis, unspecified

10.7

9.8

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

9.7

154

894

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

9.7

190

1170

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

9.7

755

6090

A02BA02

ATC

ranitidine; systemic

1.4

9.7

434

3201

J01DA01

ATC

[U] cefalexin

1.3

9.7

1418

12469

B37.08

ICD-10 Finland

Other candidal stomatitis

3.7

9.6

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

9.6

181

1104

G04CA02

ATC

tamsulosin; oral

1.4

9.6

474

3558

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

9.6

446

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

9.6

136

765

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

11.4

9.6

YNB10

NOMESCO Finland

Collection of stem cells for transplant

11.4

9.6

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.6

9.5

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.7

9.5

160

945

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.2

9.5

354

393

Kela drug reimbursment

Pomalidomide

9.1

9.5

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

9.5

150

871

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

3.0

9.5

139

E05

ICD-10 Finland

Thyrotoxicosis [hyperthyroidism]

3.7

9.4

BBA99

NOMESCO Finland

Other operations on parathyroid gland

100.4

9.4

E21.4

ICD-10 Finland

Other specified disorders of parathyroid gland

100.4

9.4

E34.9

ICD-10 Finland

Endocrine disorder, unspecified

7.6

9.4

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

30.1

9.4

I25.2

ICD-10 Finland

Old myocardial infarction

1.9

9.4

116

624

E87.3

ICD-10 Finland

Alkalosis

+∞

9.4

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

9.4

120

653

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.7

9.3

164

981

R03BB04

ATC

tiotropium bromide; inhalant

1.6

9.3

221

1428

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

3.2

9.3

114

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

4.0

9.3

N05CD07

ATC

temazepam; oral

1.5

9.3

264

1778

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.9

9.3

146

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

8.7

9.3

JFF13

NOMESCO Finland

Terminal enterostomy

10.7

9.3

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.0

9.3

472

K59.0

ICD-10 Finland

Constipation

1.9

9.3

122

670

A10AD01

ATC

insulin (human); parenteral

3.1

9.2

125

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.8

9.2

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.6

9.2

C10AC01

ATC

colestyramine; oral

2.4

9.2

276

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.8

9.2

169

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

9.2

135

767

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

9.2

192

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

4.2

9.2

ED1AA

NOMESCO Finland

Mandibular X-ray examination

4.2

9.2

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.3

9.2

100

C07AA05

ATC

propranolol; systemic

1.4

9.1

428

3180

N21.0

ICD-10 Finland

Calculus in bladder

3.6

9.1

WX720

NOMESCO Finland

Own respiration

2.0

9.1

510

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

9.1

137

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

4.4

9.1

N03AF01

ATC

carbamazepine; oral, rectal

1.9

9.1

110

588

K20

ICD-10 Finland

Oesophagitis

2.8

9.1

159

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

9.0

272

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

3.4

9.0

S18

ICPC

Laceration/cut

1.3

9.0

1055

8977

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.2

9.0

106

A10BJ06

ATC

semaglutide; parenteral

2.0

9.0

470

L04AX06

ATC

pomalidomide; oral

9.1

9.0

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.0

9.0

127

M79.7

ICD-10 Finland

Fibromyalgia

2.2

9.0

330

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.7

9.0

177

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.6

8.9

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.3

8.9

286

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.1

8.9

117

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.0

8.9

133

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

3.2

8.9

112

WF099

NOMESCO Finland

Other radiotherapy

4.2

8.9

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

24.1

8.9

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

8.9

161

D89.80

ICD-10 Finland

Immunoglobulin A (IgA) deposits in organisms

12.6

8.9

SPAT1125

SPAT

Stoma care and guidance

2.8

8.9

150

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

2.6

8.9

184

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

8.0

8.8

K70.1

ICD-10 Finland

Alcoholic hepatitis

6.8

8.8

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.1

8.8

118

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

8.8

217

1415

NF3AA

NOMESCO Finland

Femur X-ray examination

2.5

8.8

226

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

8.8

134

770

R07.3

ICD-10 Finland

Other chest pain

1.6

8.8

212

1376

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

9.5

8.8

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.4

8.8

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

7.2

8.7

K29.8

ICD-10 Finland

Duodenitis

4.1

8.7

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

14.1

8.7

H25.8

ICD-10 Finland

Other senile cataract

1.5

8.7

263

1796

E20

ICD-10 Finland

Hypoparathyroidism

50.2

8.7

163

Kela drug reimbursment

Abiraterone and enzalutamide

3.6

8.7

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.3

8.7

290

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

8.7

484

A10BJ02

ATC

liraglutide; parenteral

2.4

8.7

234

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

8.6

152

910

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

8.6

143

842

E05.80

ICD-10 Finland

Subacute thyrotoxicosis

4.0

8.6

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.5

8.6

217

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

16.3

8.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

8.5

267

1836

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

8.5

151

906

EBA00

NOMESCO Finland

Extraction of tooth

1.3

8.5

760

6230

C10AX09

ATC

ezetimibe; oral

1.5

8.5

270

1862

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.2

8.5

105

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

3.4

8.5

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

3.4

8.5

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

8.5

280

A10BX07

ATC

[U] liraglutide

3.4

8.5

E46

ICD-10 Finland

Unspecified protein-energy malnutrition

27.6

8.5

V03AE04

ATC

calcium acetate and magnesium carbonate; systemic

20.1

8.5

W19

ICD-10 Finland

Unspecified fall

1.6

8.5

209

1364

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.0

8.5

426

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.3

8.4

287

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.6

8.4

177

E85.9

ICD-10 Finland

Amyloidosis, unspecified

90.3

8.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

1.7

8.4

162

994

PE1BT

NOMESCO Finland

Femoral artery extensive PTA

4.3

8.4

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.2

8.4

320

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

8.4

469

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

8.4

269

M86.1

ICD-10 Finland

Other acute osteomyelitis

12.8

8.4

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.9

8.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

7.9

8.4

BB1AQ

NOMESCO Finland

Parathyroidgland SPECT with low dose CT

+∞

8.3

2521A

ICD-9 Finland

Disorders of parathyroid gland, Hypoparathyroidism

+∞

8.3

N16.3

ICD-10 Finland

Renal tubulo-interstitial disorders in metabolic diseases

+∞

8.3

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

2.9

8.3

133

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

8.3

103

555

A10AA01, ,

ATC

2.7

8.3

167

N28.1

ICD-10 Finland

Cyst of kidney

2.9

8.3

128

D86

ICD-10 Finland

Sarcoidosis

9.5

8.3

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

8.3

292

2058

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

7.1

8.2

WX2DD

NOMESCO Finland

Low-dose CT of skeleton in whole body

7.1

8.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

8.2

117

659

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.2

8.2

N05BA02

ATC

chlordiazepoxide; systemic

2.4

8.2

240

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

14.5

8.2

ZX080

NOMESCO Finland

Image guided radiotherapy

2.3

8.2

278

A79

ICPC

Malignancy NOS

2.7

8.2

151

C02EA02, ,

ATC

1.9

8.2

480

KBT00

NOMESCO Finland

Extracorporeal shock wave lithotripsy of ureter

6.5

8.2

N06AA09

ATC

amitriptyline; systemic

1.6

8.1

214

1417

XG466

NOMESCO Finland

Sleep oxymetry

2.2

8.1

318

WX199

NOMESCO Finland

Other local analgesia

2.1

8.1

378

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.9

8.1

517

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.1

8.1

103

R03AC02

ATC

salbutamol; inhalant

1.3

8.1

1217

10639

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

8.1

BB1BN

NOMESCO Finland

Parathyroid gland isotope imaging, 2 isotopes

17.2

8.1

L01EX07

ATC

cabozantinib; oral

11.7

8.1

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

11.7

8.1

A40.8

ICD-10 Finland

Other streptococcal sepsis

3.8

8.1

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.9

8.1

130

R5110, ,

SPAT

1.7

8.1

140

836

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.0

8.0

114

K70.4

ICD-10 Finland

Alcoholic hepatic failure

8.9

8.0

H05BX02

ATC

paricalcitol; systemic

22.1

8.0

E66.0

ICD-10 Finland

Obesity due to excess calories

3.6

8.0

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

8.0

380

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

8.0

122

702

K85.8

ICD-10 Finland

Other acute pancreatitis

4.1

8.0

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.0

1004

8585

N05AH03

ATC

olanzapine; systemic

1.8

8.0

121

695

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

3.5

8.0

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

7.2

8.0

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.3

7.9

352

Kela drug reimbursment

Abiraterone and enzalutamide

4.3

7.9

D12

ICPC

Constipation

2.0

7.9

395

SPAT1281

SPAT

Other administrative function

1.6

7.9

167

1049

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

3.3

7.9

H3600, E113,

ICD-10 Finland

3.3

7.9

J02AC01

ATC

fluconazole; systemic

1.3

7.9

848

7107

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

4.6

7.9

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

7.9

105

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

7.8

116

662

ZY000

NOMESCO Finland

Hospital inpatient

3.2

7.8

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

8.5

7.8

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.4

7.8

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.8

7.8

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

7.8

197

1293

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

7.8

834

6986

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.1

7.8

317

SAA04

NOMESCO Finland

Special examination of mouth

1.8

7.8

115

656

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

7.8

426

SPAT1312

SPAT

General health counselling

1.3

7.8

690

5642

C03BA11

ATC

indapamide; oral

2.2

7.7

298

R4130

NOMESCO Finland

Speech therapy

2.4

7.7

228

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.2

7.7

266

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.7

7.7

156

M821, E2109,

ICD-10 Finland

45.1

7.7

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.5

7.7

TQW99

NOMESCO Finland

Other minor procedure on skin

1.8

7.7

115

658

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

2.6

7.7

168

C09CA06

ATC

candesartan; oral

1.3

7.7

505

3956

L29.8

ICD-10 Finland

Other pruritus

3.0

7.7

112

JMA10

NOMESCO Finland

Transabdominal total splenectomy

4.5

7.6

A06AC51

ATC

ispaghula, combinations; oral

1.8

7.6

106

593

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

7.6

140

849

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.2

7.6

261

N03AE01

ATC

clonazepam; systemic

1.7

7.6

123

720

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

4.0

7.6

N25.0

ICD-10 Finland

Renal osteodystrophy

18.4

7.6

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

8.0

7.6

168

Kela drug reimbursment

Axitinib

25.1

7.6

PB1AC

NOMESCO Finland

Angiography of upper extremity with X-ray

25.1

7.6

I20.09

ICD-10 Finland

Unstable angina

1.8

7.6

100

551

A10BK01

ATC

dapagliflozin; oral

1.7

7.6

131

782

N02BF01

ATC

gabapentin; oral

1.6

7.6

167

1062

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.7

7.6

152

R51.80

ICD-10 Finland

Headache

1.4

7.5

301

2170

K65.9

ICD-10 Finland

Peritonitis, unspecified

8.9

7.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.1

7.5

308

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

3.2

7.5

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

7.5

272

1925

S06.0

ICD-10 Finland

Concussion

1.5

7.5

213

1434

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.7

7.5

147

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

7.5

135

815

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

7.5

336

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.9

7.4

114

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

7.4

290

D07AA02

ATC

hydrocortisone; topical

1.5

7.4

276

1965

E000001, ,

ATC

1.4

7.4

412

3146

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

7.4

147

911

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

7.4

480

3753

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.9

7.4

527

P01BA02

ATC

hydroxychloroquine; oral

1.6

7.4

183

1197

J01XX08

ATC

linezolid; systemic

4.0

7.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

7.3

1208

10629

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

7.3

363

2718

M05BA07

ATC

risedronic acid; oral

2.0

7.3

400

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

7.3

421

SPAT1153

SPAT

Removal of sutures

1.3

7.3

727

6024

A29

ICPC

General symptom/complaint other

1.5

7.3

263

1860

E89.1

ICD-10 Finland

Postprocedural hypoinsulinaemia

+∞

7.3

8010/3-C75.0

ICD-O-3

Carcinoma, NOS, of parathyroid gland

+∞

7.3

2581B

ICD-9 Finland

Polyglandular dysfunction and related disorders, Other combinations of endocrine dysfunction[AUTOIMMUNE-POLYENDOCRINOPATHY-CANDIDOSIS-ECTOD DYST]

+∞

7.3

N16.2

ICD-10 Finland

Renal tubulo-interstitial disorders in blood diseases and disorders involving the immune mechanism

+∞

7.3

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

7.3

339

UDC00

NOMESCO Finland

Ear microscopy

1.6

7.3

161

1024

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.6

7.3

155

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.9

7.3

472

R25.1

ICD-10 Finland

Tremor, unspecified

2.1

7.2

340

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

6.2

7.2

GD6AD

NOMESCO Finland

CT of chest and neck

6.2

7.2

158

Kela drug reimbursment

Everolimus

15.8

7.2

Z00.0

ICD-10 Finland

General medical examination

1.4

7.2

410

3139

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.2

7.2

248

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

5.8

7.2

I50.1

ICD-10 Finland

Left ventricular failure

1.9

7.2

502

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.4

7.2

198

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

7.2

570

4582

2505

FHL

Bilateral resection (also used if total removal has been performed on the other side)

3.7

7.2

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.2

417

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

7.2

209

1416

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

7.2

106

605

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.5

7.2

254

1791

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

3.9

7.2

JA3FT

NOMESCO Finland

Exchange abdominal catheter with radiological guidance

30.1

7.1

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

30.1

7.1

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.1

236

1641

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

3.6

7.1

4CJ01, ,

NOMESCO Finland

20.1

7.1

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.9

7.1

106

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

7.1

461

A03

ICPC

Fever

1.4

7.1

310

2271

K06.18

ICD-10 Finland

Another gingival hyperplasia

6.6

7.1

M80

ICD-10 Finland

Osteoporosis with pathological fracture

3.4

7.1

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

7.1

534

TPX15

NOMESCO Finland

Removal of vascular injection port

6.0

7.1

PC5DE

NOMESCO Finland

Ultrasound of kidney circulation with Doppler technic

6.0

7.1

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.0

7.1

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

7.1

123

SPAT1251

SPAT

Organisation of medication

2.0

7.0

371

J01FA06

ATC

roxithromycin; oral

1.3

7.0

876

7454

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

10.0

7.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

7.0

152

Z31.5

ICD-10 Finland

Genetic counselling

1.8

7.0

104

594

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.9

7.0

107

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

7.0

165

1066

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

7.0

A10BX04

ATC

[U] exenatide

3.5

7.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

7.0

108

625

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.9

7.0

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.4

7.0

201

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.6

7.0

141

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

3.0

7.0

102

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

4.4

7.0

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.4

7.0

195

C02CA01

ATC

prazosin; oral

2.6

7.0

147

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.6

6.9

153

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.0

6.9

339

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

6.9

178

1174

N06AB06

ATC

sertraline; oral

1.5

6.9

218

1502

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

5.8

6.9

M87.1

ICD-10 Finland

Osteonecrosis due to drugs

5.8

6.9

ZY010

NOMESCO Finland

Hospital outpatient

1.8

6.9

509

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

6.9

299

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.1

6.9

7151

FHL

Kidney transplantation

13.8

6.9

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

3.6

6.9

K77

ICPC

Heart failure

2.4

6.9

184

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

2.5

6.8

160

K07

ICPC

Swollen ankles/oedema

1.8

6.8

101

577

OAB50, ,

SPAT

1.7

6.8

111

652

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

3.0

6.8

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.8

6.8

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

6.8

298

2185

B74

ICPC

Malignant neoplasm blood other

11.0

6.8

D86.3

ICD-10 Finland

Sarcoidosis of skin

11.0

6.8

WZA10

NOMESCO Finland

Extensive medical or dental certificate

2.9

6.8

109

207

Kela drug reimbursment

Chronic arrhythmias

1.4

6.8

325

2420

N18

ICPC

Paralysis/weakness

2.5

6.8

173

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

6.8

527

G41.9

ICD-10 Finland

Status epilepticus, unspecified

6.1

6.8

SPAT1139

SPAT

Nutrition survey

2.0

6.8

356

G63.8*N18.8

ICD-10 Finland

Uraemic neuropathy

40.2

6.8

L01XE33

ATC

[U] palbociclib

4.3

6.7

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.1

6.7

295

D10

ICPC

Vomiting

1.8

6.7

528

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

6.7

153

981

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

7.2

6.7

L01XE26

ATC

[U] cabozantinib

22.6

6.7

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

6.6

274

1987

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

6.4

6.6

D21

ICPC

Swallowing problem

2.6

6.6

139

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

7.8

6.6

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

7.8

6.6

K02.9

ICD-10 Finland

Dental caries, unspecified

2.5

6.6

151

PJA10

NOMESCO Finland

Exploration of lymph nodes

2.7

6.6

122

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

5.9

6.6

I20.00

ICD-10 Finland

Unstable angina

2.2

6.6

232

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

12.3

6.6

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.9

6.6

402

G72.9

ICD-10 Finland

Myopathy, unspecified

3.5

6.6

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

1.7

6.5

104

607

J96.0

ICD-10 Finland

Acute respiratory failure

3.0

6.5

A02

ICPC

Chills

3.8

6.5

N05CF02

ATC

zolpidem; oral

1.4

6.5

359

2733

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

6.5

548

K56.7

ICD-10 Finland

Ileus, unspecified

2.5

6.5

152

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.2

6.5

233

Y88

ICD-10 Finland

Sequelae with surgical and medical care as external cause

3.7

6.5

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.4

6.5

183

A10BK03

ATC

empagliflozin; oral

1.5

6.5

178

1192

L60.0

ICD-10 Finland

Ingrowing nail

1.8

6.5

520

UJD02

NOMESCO Finland

Gastroscopy

1.8

6.5

557

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

5.3

6.5

ZX121

NOMESCO Finland

Central venous catheter

5.7

6.4

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

6.4

441

3469

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.1

6.4

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.5

6.4

Z73.6

ICD-10 Finland

Limitation of activities due to disability

3.5

6.4

E87.7

ICD-10 Finland

Fluid overload

70.0

6.4

WX204

NOMESCO Finland

Axillary plexus blockaced

1.9

6.4

398

WPA44

NOMESCO Finland

Nursing home for palliative care

14.3

6.4

C07AB05

ATC

betaxolol; oral

2.1

6.4

255

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.2

6.4

216

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

4.1

6.4

TGD00

NOMESCO Finland

Needle biopsy of lung

4.1

6.4

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

6.4

163

1075

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.0

6.3

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

6.3

567

4625

TAB00

NOMESCO Finland

Lumbar puncture

1.8

6.3

531

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

5.2

6.3

L02BX03

ATC

abiraterone; oral

3.6

6.3

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

6.0

6.3

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

11.0

6.3

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.8

6.3

495

WW409

NOMESCO Finland

Other aferesis

9.3

6.3

H01CB03

ATC

lanreotide; parenteral

9.3

6.3

L03

ICPC

Low back symptom/complaint

1.3

6.3

568

4638

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

3.3

6.3

K90

ICPC

Stroke/cerebrovascular accident

2.1

6.3

250

S70.0

ICD-10 Finland

Contusion of hip

1.8

6.3

452

E85.3

ICD-10 Finland

Secondary systemic amyloidosis

+∞

6.3

PBM09

NOMESCO Finland

Closure of arteriovenous fistula of brachial artery

+∞

6.3

PB1ST

NOMESCO Finland

Thrombolysis of upper extremity artery

+∞

6.3

C73.94

ICD-10 Finland

Medullary thyroid carcinoma (thyroid)

+∞

6.3

PG5ST

NOMESCO Finland

Endovascular thrombolysis of arterio-venous shunt for dialysis with radiological guidance

+∞

6.3

M821, E8358,

ICD-10 Finland

+∞

6.3

L01XE17

ATC

[U] axitinib

+∞

6.3

E83.8

ICD-10 Finland

Other disorders of mineral metabolism

+∞

6.3

Angiography of the heart and coronary arteries

1.7

6.2

103

608

TQW80

NOMESCO Finland

Local dermatologic skincare

2.1

6.2

284

KAS40

NOMESCO Finland

Excision of transplanted kidney

26.7

6.2

4039A

ICD-9 Finland

Hypertensive renal disease, Unspecified

26.7

6.2

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

6.2

346

V03AA01, ,

ATC

2.6

6.2

126

WX722

NOMESCO Finland

PEEP

1.8

6.2

534

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.1

6.2

271

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

2.9

6.2

A07DA03

ATC

loperamide; oral

1.9

6.2

389

N05AX08

ATC

risperidone; systemic

1.5

6.2

162

1074

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

4.0

6.2

JF1AD

NOMESCO Finland

Small bowel CT

3.5

6.2

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.1

6.2

272

B82

ICPC

Anaemia other/unspecified

2.1

6.2

272

GBB00

NOMESCO Finland

Tracheostomy

2.8

6.2

104

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

6.2

163

1083

J01AA02

ATC

doxycycline; systemic

1.2

6.1

1841

17139

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

5.3

6.1

A10AB06

ATC

insulin glulisine; parenteral

3.2

6.1

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

5.7

6.1

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.7

6.1

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

5.7

6.1

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.9

6.1

355

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

7.7

6.1

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.1

187

1281

J20

ICD-10 Finland

Acute bronchitis

1.5

6.1

199

1381

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.3

6.1

201

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

4.1

6.1

A02BC04

ATC

rabeprazole; oral

1.5

6.1

181

1233

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.0

6.1

335

D07AB08

ATC

desonide; topical

1.5

6.1

215

1516

E000003, ,

ATC

1.8

6.1

471

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

12.5

6.1

N05AX12

ATC

aripiprazole; systemic

2.0

6.0

308

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.1

6.0

274

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.6

6.0

134

R04.0

ICD-10 Finland

Epistaxis

1.5

6.0

154

1015

A07AA11

ATC

rifaximin; oral

6.7

6.0

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

6.7

6.0

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

10.0

6.0

L86

ICPC

Back syndrome with radiating pain

1.6

6.0

123

769

WX610

NOMESCO Finland

Patient controlled analgesia

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3004588) Protein electrophoresis panel - Serum or Plasma

655

1370

6.04

310.43

3.7

2.4

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1530

2303

14.51

307.65

10.6

5.0

1.04

1.03

mmol/l

0.22

1459

2128

(3010838) Calcium [Moles/time] in 24 hour Urine

791

305

36.68

307.65

2.7

1.8

5.58

5.14

mmol/24h

1.26

710

262

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

465

577

9.58

307.65

4.6

3.5

78.18

50.23

mg/l

0.42

362

468

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2074

9424

6.70

307.65

20.5

5.0

1.24

1.22

mmol/l

14.48

1990

8484

(3034860) Kappa light chains.free [Mass/volume] in Serum

469

579

9.64

307.65

4.6

3.5

62.05

64.37

mg/l

0.06

366

466

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

397

336

13.74

307.65

4.1

2.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1456

1398

22.12

307.65

6.0

3.3

86.27

86.25

ng/l

0.00

1251

1180

(3018418) pH of Serum or Plasma

1569

6030

4.98

307.65

16.5

3.5

7.40

0.59

412

1190

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1357

3018

8.23

307.65

6.3

3.2

0.78

0.82

mmol/l

23.18

1292

2810

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

461

557

9.83

307.65

4.4

3.4

3.39

1.76

ratio

0.37

(3020779) Urea [Moles/volume] in Serum or Plasma

734

1557

6.15

307.65

14.7

6.2

12.58

9.43

mmol/l

21.65

708

1486

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1960

8599

6.04

307.65

4.3

2.1

76.36

79.27

nmol/l

3.52

1849

7590

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2275

10385

9.89

307.65

25.0

5.6

1.24

1.22

mmol/l

15.70

1960

8731

(40760888) Immunoglobulin light chains.free panel - Serum

375

443

9.71

299.45

4.4

3.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

483

794

7.23

290.67

3.1

1.8

41.01

39.57

u/l

0.58

424

702

(3020630) Protein [Mass/volume] in Serum or Plasma

694

1646

5.37

284.06

3.9

2.5

65.02

66.60

g/l

4.72

629

1504

(3015377) Calcium [Moles/volume] in Serum or Plasma

1614

7252

4.18

280.42

6.0

3.4

2.39

2.36

mmol/l

3.18

1464

6320

(3024561) Albumin [Mass/volume] in Serum or Plasma

1797

8835

4.27

270.96

9.9

4.4

33.67

35.56

g/l

31.55

1708

8162

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

229

150

16.63

266.15

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

361

509

8.06

248.21

2.9

1.9

13.89

11.71

mg/l

2.11

322

470

(3036481) Cortisol [Moles/volume] in Serum or Plasma

634

1618

4.85

234.24

2.4

2.3

378.87

363.99

nmol/l

0.91

597

1480

(3012544) pH of Venous blood

654

1737

4.68

229.49

8.7

3.5

7.37

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

642

1702

4.67

225.50

9.0

3.4

5.85

kpa

0.00

627

1643

(3002032) Base excess in Venous blood by calculation

635

1693

4.63

221.10

9.0

3.5

2.29

2.07

mmol/l

0.57

558

1415

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

786

2535

4.00

210.64

4.9

2.3

21.68

22.87

1.39

678

2179

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

726

2222

4.13

209.33

4.9

4.3

260.01

248.67

u/l

0.86

690

2100

(3004789) Transferrin [Mass/volume] in Serum or Plasma

812

2719

3.88

205.53

4.8

2.2

2.18

2.33

g/l

10.40

765

2515

(3022948) Iron [Moles/volume] in Serum or Plasma

852

2960

3.78

204.04

4.7

2.2

11.46

13.22

umol/l

10.67

797

2768

(3023368) Bacteria identified in Blood by Culture

1201

5394

3.26

188.00

7.5

4.0

—

(3009343) pH of Capillary blood

475

1177

4.71

178.99

6.0

3.5

7.42

7.41

0.59

134

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

478

1197

4.66

177.68

6.1

3.5

5.10

5.17

kpa

0.92

459

1142

(3037756) Immunofixation for Serum or Plasma

275

417

7.25

175.71

2.3

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

463

1145

4.69

174.68

5.9

3.5

2.04

1.86

mmol/l

0.40

357

854

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1825

10829

3.24

169.42

10.6

6.0

10.59

11.48

umol/l

2.07

1758

10246

(3000991) Gas panel - Venous blood

539

1539

4.15

168.04

11.7

6.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1693

9660

3.12

167.80

9.7

6.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

444

1106

4.63

165.54

4.3

3.0

4.41

4.45

pmol/l

0.17

398

974

(3013115) Eosinophils [#/volume] in Blood

1783

10631

3.11

160.22

8.6

5.8

0.19

e9/l

0.14

1611

9310

(3006315) Basophils [#/volume] in Blood

1740

10289

3.05

157.66

8.3

5.6

0.04

e9/l

0.13

1564

8892

(3001604) Monocytes [#/volume] in Blood

1733

10260

3.02

156.00

8.3

5.6

0.64

0.58

e9/l

4.89

1562

8873

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

478

1324

4.19

154.54

2.3

1.6

—

(3012565) Volume of 24 hour Urine

126

16.92

149.90

3.0

2.6

2123.19

1917.83

0.72

119

(3019069) Monocytes/100 leukocytes in Blood

1650

9651

2.91

149.30

9.1

6.1

8.65

8.66

0.03

1568

8975

(3019198) Lymphocytes [#/volume] in Blood

1749

10558

2.96

148.96

8.5

5.7

1.76

1.92

e9/l

3.15

1598

9330

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2312

16430

4.40

148.83

15.5

7.1

89.62

78.19

u/l

14.50

2253

15368

(3022217) INR in Platelet poor plasma by Coagulation assay

1631

9513

2.88

147.81

16.2

14.1

1.21

1.28

inr

3.27

548

2769

(3006504) Eosinophils/100 leukocytes in Blood

1640

9595

2.89

147.71

8.8

5.8

2.60

2.86

5.26

1558

8908

(3022096) Basophils/100 leukocytes in Blood

1605

9297

2.87

147.14

8.9

5.9

0.65

0.68

1.71

1519

8615

(3024354) Oxygen [Partial pressure] in Venous blood

492

1442

3.97

146.61

7.1

2.9

4.78

4.58

kpa

0.97

475

1392

(3013650) Neutrophils [#/volume] in Blood by Automated count

1898

12080

3.06

144.54

15.4

8.8

4.46

4.02

e9/l

11.05

1736

10533

(3013826) Glucose [Moles/volume] in Serum or Plasma

1898

12089

3.05

144.16

9.4

4.0

6.80

6.64

mmol/l

3.00

1843

11241

(3027945) Reticulocytes/100 erythrocytes in Blood

633

2217

3.44

144.12

3.8

2.5

1.95

1.76

4.38

571

1968

(3026493) Urate [Moles/volume] in Serum or Plasma

1097

5263

2.86

143.82

4.8

2.5

1410.77

4979.74

umol/l

4.42

990

4542

(3002030) Lymphocytes/100 leukocytes in Blood

1665

9904

2.86

143.72

9.0

5.9

24.62

28.04

27.20

1579

9230

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

338

754

5.00

143.42

3.8

2.3

7.51

7.33

g/l

0.93

297

683

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

337

754

4.98

142.46

3.8

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

336

753

4.97

141.74

3.9

2.3

3.79

3.64

g/l

0.71

296

683

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

118

17.11

141.34

7.0

6.7

—

(3005719) IgG [Mass/volume] in Serum or Plasma

483

1438

3.89

140.37

3.9

2.9

10.33

10.61

g/l

0.46

442

1314

(3023520) Reticulocytes [#/volume] in Blood

525

1667

3.69

138.69

3.6

2.7

69.60

68.44

e9/l

0.26

424

1252

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1250

6507

2.76

138.68

3.7

2.4

58.19

60.54

u/l

0.62

1185

5972

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

346

813

4.75

137.69

2.1

1.8

1.70

1.51

g/l

2.60

301

698

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

317

707

4.96

134.27

3.9

2.3

9.48

10.45

g/l

2.70

276

630

(3028026) IgM [Mass/volume] in Serum or Plasma

404

1096

4.17

133.34

2.6

2.0

1.12

1.44

g/l

2.39

361

997

(21494890) Protein electrophoresis panel - 24 hour Urine

165

192

9.10

131.42

3.0

1.9

—

(3018010) Neutrophils/100 leukocytes in Blood

1618

9753

2.72

131.32

8.5

5.7

60.00

57.02

17.26

1541

9076

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1044

5077

2.75

130.68

2.7

2.2

3.32

3.04

mg/l

2.35

911

4342

(3020876) Protein [Mass/time] in 24 hour Urine

161

183

9.31

130.58

3.4

2.2

0.94

1.37

g/24h

0.52

110

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

531

1765

3.52

130.20

14.6

3.2

1.24

1.23

mmol/l

1.39

504

1516

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

311

712

4.82

127.44

3.9

2.3

2.96

2.97

g/l

0.06

270

642

(3015235) Bicarbonate [Moles/volume] in Capillary blood

236

427

5.97

126.02

4.8

2.8

24.52

24.96

mmol/l

0.61

230

417

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

344

863

4.44

125.63

8.5

4.0

24.15

24.20

mmol/l

0.08

339

844

(1616796) Gas panel - Central venous blood

225

393

6.17

124.56

5.2

3.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

255

516

5.37

120.54

1.5

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

749

3188

2.89

119.34

2.4

1.7

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

288

658

4.79

118.05

4.0

2.4

0.92

1.17

g/l

0.39

229

573

(3004119) Hemoglobin [Mass/volume] in Venous blood

381

1096

3.90

115.12

7.6

2.8

118.18

128.84

g/l

15.78

373

1065

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

133

139

10.03

114.72

6.2

4.1

89.01

42.01

u/ml

0.38

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1429

8462

2.51

114.62

4.7

2.6

239.60

127.97

ug/l

10.62

1335

7751

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

300

732

4.50

113.15

2.8

2.0

2.59

2.32

ug/l

0.09

271

651

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

851

3972

2.69

112.48

4.7

3.1

2.54

2.45

mmol/l

12.31

752

3516

(3002582) Erythrocytes [#/volume] in Urine

1133

6095

2.51

111.02

5.2

2.9

55.53

90.83

e6/l

1.09

940

4654

(3027273) Bicarbonate [Moles/volume] in Venous blood

330

888

4.11

109.24

8.6

2.8

25.45

25.48

mmol/l

0.03

322

856

(3021901) Oxygen saturation in Capillary blood

187

310

6.42

108.87

3.8

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1106

5948

2.48

107.64

2.6

1.9

207.49

227.97

u/l

0.23

1054

5539

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

196

347

6.02

106.76

7.4

4.4

391.78

298.35

iu/ml

0.39

(3028626) Oxygen [Partial pressure] in Capillary blood

216

420

5.51

106.47

4.6

3.3

8.20

8.37

kpa

0.70

211

412

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

233

489

5.13

105.36

5.4

4.2

2.05

1.45

mg/l

12.74

213

448

(3022313) Gas panel - Capillary blood

324

885

4.04

104.91

6.1

3.7

—

(3026782) Osmolality of Urine

835

3990

2.60

103.88

4.4

2.7

492.43

547.22

mosm/kgh2o

11.79

755

3393

(3026008) Bacteria identified in Urine by Culture

1160

6503

2.40

101.40

4.2

3.0

—

(3018095) Leukocytes [#/volume] in Urine

1239

7151

2.39

101.32

6.0

3.3

148.01

113.45

e6/l

0.67

983

5044

(3044640) Blood type and Crossmatch panel - Blood

1165

6557

2.40

100.76

3.6

2.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

189

345

5.83

99.62

3.6

2.8

33.57

35.69

umol/l

0.50

167

311

(3017181) Myelocytes/100 leukocytes in Blood

474

1722

3.14

98.54

5.2

4.0

0.93

0.02

262

559

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

246

572

4.64

98.24

3.9

2.2

0.04

0.02

g/l

0.77

212

531

(3007164) IgA [Mass/volume] in Serum or Plasma

792

3786

2.56

97.49

2.2

1.4

2.76

2.46

g/l

0.99

538

2247

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

252

604

4.51

96.84

3.8

2.2

36.03

37.80

g/l

3.34

211

532

(3037121) Protein [Mass/volume] in Urine

273

699

4.24

96.26

3.9

3.0

0.50

0.24

g/l

3.39

142

269

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

364

1140

3.55

96.19

8.8

6.7

24.80

25.07

mmol/l

0.57

358

1134

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1521

9745

2.33

95.58

3.7

2.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

650

2866

2.68

93.99

2.5

2.1

29.61

29.70

0.13

628

2767

(3030467) Casts [#/volume] in Urine by Automated count

1034

5659

2.36

93.72

4.7

2.9

0.57

0.41

e6/l

1.13

853

4317

(3014111) Lactate [Moles/volume] in Serum or Plasma

453

1648

3.11

93.64

9.6

5.7

1.46

1.35

mmol/l

0.74

441

1611

(3013707) Erythrocyte sedimentation rate by Westergren method

2115

15767

2.75

93.54

6.3

4.0

18.97

12.25

mm/h

40.08

1996

14507

(3021440) Promyelocytes/100 leukocytes in Blood

452

1647

3.11

93.14

5.2

4.1

0.15

0.11

0.63

241

488

(3017704) Immunofixation for Urine

10.91

91.23

1.8

1.7

—

(3000850) Epithelial cells [#/volume] in Urine

848

4308

2.43

90.39

4.1

2.4

5.20

5.72

e6/l

0.62

792

3819

(3016502) Oxygen saturation in Arterial blood

489

1899

2.94

89.76

8.4

6.5

94.88

95.65

1.29

471

1831

(3002179) Metamyelocytes/100 leukocytes in Blood

437

1594

3.09

89.67

5.1

3.9

0.70

0.68

0.08

236

494

(3019309) Folate [Moles/volume] in Red Blood Cells

793

3928

2.46

89.21

2.0

1.7

1308.25

1170.53

nmol/l

2.83

624

2939

(3004809) Band form neutrophils/100 leukocytes in Blood

174

326

5.65

89.08

3.4

3.6

1.44

1.45

0.01

159

285

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

226

534

4.54

88.26

4.0

2.3

0.00

g/l

-0.00

192

496

(3037467) Urinalysis macro (dipstick) panel - Urine

1982

14540

2.48

86.78

7.1

4.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1273

7790

2.23

86.39

5.4

3.2

43.88

114.35

ng/l

0.63

1039

5369

(3003396) Base excess in Arterial blood by calculation

524

2154

2.79

86.20

8.1

6.1

1.10

1.21

mmol/l

0.18

429

1688

(3009508) Creatinine [Moles/volume] in Urine

1085

6239

2.26

85.63

4.4

3.0

6.46

7.46

mmol/l

13.63

955

5210

(3031040) Bacteria [#/volume] in Urine by Automated count

1922

13961

2.40

85.18

6.8

4.3

1559.12

2090.32

e6/l

0.19

165

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

220

529

4.45

83.95

4.0

2.3

0.00

g/l

-0.00

192

495

(3027801) Oxygen [Partial pressure] in Arterial blood

520

2171

2.74

82.73

8.1

6.1

11.55

12.41

kpa

3.30

502

2064

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

520

2171

2.74

82.73

8.1

6.1

5.05

5.14

kpa

1.11

501

2063

(3025159) Blasts/100 leukocytes in Blood

421

1573

3.00

82.39

5.1

4.1

0.05

0.66

1.24

208

416

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1024

5831

2.24

81.91

3.6

2.8

2897.88

1250.97

ng/l

5.73

903

4934

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

151

268

5.92

81.79

4.0

3.1

492.91

1713.67

u/ml

0.69

(36304419) Bacteria [Presence] in Urine

983

5515

2.25

81.45

4.5

2.8

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1346

8558

2.17

81.36

2.4

1.9

94.70

95.54

pmol/l

0.23

738

4335

(3009445) Proteinase 3 Ab [Units/volume] in Serum

275

801

3.72

80.56

1.3

1.5

2.94

26.30

u/ml

—

(40767503) Oxygen content in Capillary blood by calculation

183

393

4.93

80.20

3.7

2.2

15.27

16.38

2.29

113

180

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

283

844

3.64

80.02

6.6

2.5

0.67

0.65

0.27

283

839

(3042936) Bacteria identified in Isolate by Culture

610

2801

2.53

79.67

2.7

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

468

1904

2.77

77.92

3.1

2.2

0.20

0.21

g/l

2.53

433

1792

(40768446) Kidney Pathology biopsy report

13.06

77.88

1.9

1.4

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

506

2148

2.68

77.48

2.1

1.6

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

281

853

3.57

77.28

8.2

3.3

49.17

49.02

0.03

275

838

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

228

603

4.05

76.54

3.7

3.0

0.31

0.34

u/ml

0.68

125

342

(3003181) Sodium [Moles/volume] in Urine

121

184

6.85

76.30

2.3

1.3

60.85

69.85

mmol/l

1.11

103

137

(3047189) Immunofixation for 24 hour Urine

9.97

76.30

2.9

1.6

—

(3010421) pH of Blood

207

515

4.28

75.43

6.7

3.7

7.43

7.42

0.34

185

467

(3002173) Hemoglobin [Mass/volume] in Arterial blood

439

1756

2.80

75.33

9.0

6.8

113.97

121.22

g/l

9.40

431

1705

(3017143) Hepatitis C virus Ab [Presence] in Serum

471

1959

2.71

74.91

2.2

1.5

—

(3026250) Tacrolimus [Mass/volume] in Blood

13.24

74.38

43.5

29.2

7.15

7.18

ug/l

0.02

(3021960) Folate [Moles/volume] in Serum or Plasma

875

4824

2.22

74.32

1.9

1.5

19.93

20.89

nmol/l

0.69

751

4040

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

498

2150

2.62

73.38

2.1

1.7

—

(3012516) Albumin [Mass/volume] in Urine

1009

5911

2.15

73.23

4.6

3.1

1154.60

276.17

mg/l

3.62

754

3621

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

13.66

72.59

1.7

1.4

0.35

0.41

ug/l

0.23

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

263

797

3.56

72.38

6.7

3.8

24.97

24.94

mmol/l

0.06

251

745

(3007853) Bacteria identified in Skin by Aerobe culture

520

2315

2.55

71.77

2.1

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

193

473

4.32

71.67

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

894

5039

2.17

71.24

3.5

2.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2078

16152

2.37

70.30

6.8

3.9

15.50

14.82

pmol/l

20.68

1941

14495

(3044927) Protein electrophoresis panel - Urine

123

207

6.18

70.26

1.3

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1038

6224

2.10

70.15

5.4

3.6

39.28

6.78

mg/mmol

1.52

754

3761

(3019225) pH of Specimen

511

2279

2.54

70.13

15.9

3.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

106

157

6.99

68.46

2.5

1.8

6.70

3.81

mg/l

4.82

149

(4035726) Immunohistochemistry procedure

455

1941

2.63

68.33

1.6

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

180

438

4.34

67.41

6.1

4.0

8.70

8.44

kpa

1.07

174

432

(3012501) Base excess in Blood by calculation

179

434

4.35

67.35

6.1

3.9

3.07

2.75

mmol/l

0.68

141

298

(3013290) Carbon dioxide [Partial pressure] in Blood

179

435

4.34

67.15

6.1

3.9

5.05

kpa

0.01

173

429

(3024928) Oxygen saturation in Venous blood

154

339

4.76

65.38

5.8

2.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

518

2398

2.45

65.18

2.2

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1035

6360

2.04

63.98

4.4

3.0

35.05

33.52

u/l

0.37

981

5994

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

310

1117

3.01

63.93

1.8

1.4

—

(3000012) Reticulocyte production index

134

267

5.23

63.91

2.2

2.3

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

176

441

4.21

63.37

2.1

1.7

4.42

4.55

iu/l

0.07

139

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

140

301

4.86

61.11

1.3

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

153

355

4.51

60.83

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

1459

10241

1.96

60.15

5.5

3.6

0.00

estimate

0.31

401

2076

(3017817) Protein [Mass] in Urine collected for unspecified duration

156

6.49

59.09

2.5

2.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

564

2824

2.27

58.66

2.3

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

18.71

57.87

1.5

1.3

108.91

121.04

ng/l

0.11

(3009261) Glucose [Presence] in Urine by Test strip

1458

10369

1.91

56.27

5.6

3.6

0.01

0.00

estimate

0.16

374

1900

(3021601) Nitrite [Presence] in Urine by Test strip

1443

10228

1.91

56.27

7.3

4.7

0.00

estimate

0.37

380

1944

(3037522) Nuclear Ab [Titer] in Serum

529

2620

2.28

56.25

1.5

1.3

473.14

555.76

titre

0.53

105

557

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

491

3.79

55.27

2.0

1.5

—

(3042733) HLA Ab [Presence] in Serum

12.86

54.68

5.6

5.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

109

208

5.42

54.50

1.5

1.4

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

122

259

4.89

54.02

7.6

6.5

13.30

11.61

mg/l

3.13

107

242

(3019060) Gas panel - Arterial blood

317

1263

2.72

53.86

5.6

4.4

—

(3033658) Prothrombin time (PT) actual/Normal

839

5029

1.98

53.57

6.7

3.7

91.43

89.90

0.96

816

4890

(3008152) Bicarbonate [Moles/volume] in Arterial blood

303

1183

2.76

53.53

8.0

6.5

24.58

24.64

mmol/l

0.08

290

1125

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1747

13313

1.93

53.19

4.7

2.9

73.88

46.91

u/l

12.12

1641

12266

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

143

353

4.23

52.43

1.5

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

313

1259

2.69

52.12

1.6

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

146

368

4.14

52.06

2.1

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

102

192

5.49

51.76

1.3

1.2

72.36

62.12

u/l

0.47

170

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

201

634

3.35

51.58

2.4

2.1

414.55

711.98

ug/l

0.43

191

592

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

137

332

4.30

51.45

1.6

1.2

292.84

278.36

u/ml

0.20

202

(3006184) Hemoglobin [Mass/volume] in Capillary blood

153

404

3.96

51.19

3.2

2.1

119.49

129.71

g/l

4.31

134

284

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

454

2188

2.30

51.09

5.3

3.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

466

2271

2.28

51.07

3.2

4.1

41.77

23.50

ug/l

0.69

397

1846

(3025549) Creatine [Moles/time] in 24 hour Urine

19.78

50.28

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

168

482

3.66

49.88

2.1

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

430

3.82

49.88

1.6

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

578

3099

2.11

49.71

4.4

2.7

3.08

2.70

e6/l

0.40

342

1681

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

142

363

4.08

49.66

2.1

1.6

—

(3011985) Renin [Units/volume] in Plasma

105

211

5.14

49.54

2.4

1.3

77.29

37.70

mu/l

0.58

183

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

619

3423

2.06

48.90

3.8

2.6

1.33

1.22

e6/l

0.23

378

1991

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

742

4378

1.97

48.80

1.9

1.7

1.46

1.25

mg/l

1.02

578

3322

(3015736) pH of Urine

1182

8171

1.81

46.83

4.7

3.3

5.84

5.83

0.01

544

(3017354) Segmented neutrophils/100 leukocytes in Blood

103

214

4.97

46.76

3.2

3.7

63.50

54.94

2.87

177

(3021589) Normoblasts [#/volume] in Blood

1306

9306

1.80

46.70

20.1

8.9

0.00

e9/l

0.04

1112

7634

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

174

5.44

46.44

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

136

6.11

46.32

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

215

753

3.02

46.20

6.5

4.4

1.61

1.58

0.17

204

700

(3002079) Sodium [Moles/time] in 24 hour Urine

10.18

46.08

1.4

158.17

150.96

mmol/24h

0.22

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

192

632

3.20

45.87

1.7

1.6

391.67

231.88

titre

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

181

5.29

45.48

2.5

2.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

754

4570

1.91

45.19

1.9

1.7

478.84

33439758.42

pmol/l

3.77

624

3774

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

249

957

2.77

45.09

11.1

8.0

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

130

335

4.03

44.95

1.9

1.4

108.71

125.78

u/ml

0.61

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

733

4420

1.91

44.51

1.3

1.11

1.54

u/ml

0.67

195

1148

(3013512) EKG study

966

6375

1.81

43.89

5.0

3.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

210

747

2.97

43.86

6.5

4.4

0.88

0.89

0.06

201

694

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

9.15

43.42

3.1

2.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

201

705

3.00

43.03

4.6

3.9

1.51

1.31

mmol/l

1.01

195

700

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2411

21233

2.65

42.90

34.7

12.8

25.18

23.77

mg/l

1.33

2189

16560

(3000570) Elastase.pancreatic [Mass/mass] in Stool

182

604

3.16

42.86

1.4

237.71

287.11

ug/g

2.46

116

348

(40768797) Stomach Pathology biopsy report

524

2850

2.05

42.67

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

169

538

3.29

42.63

1.7

1.6

0.25

0.23

g/l

1.18

158

514

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

172

558

3.23

42.05

1.7

1.5

1.17

1.16

g/l

0.08

162

534

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

113

276

4.23

41.97

1.8

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

161

5.36

41.78

3.4

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

15.86

41.76

17.5

7.8

4.78

5.90

mmol/l

1.12

(3048929) Epstein Barr virus Ab [Presence] in Serum

166

533

3.26

41.27

1.5

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

193

678

2.99

41.17

2.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

243

971

2.66

40.68

9.8

7.7

23.87

24.48

mmol/l

1.58

235

940

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2260

19472

2.15

40.52

8.1

4.6

1.93

1.95

mu/l

0.13

2123

17603

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

169

555

3.19

40.48

2.6

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

268

1129

2.53

40.24

2.1

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

253

4.28

39.70

1.2

1.3

0.18

0.46

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

104

249

4.31

39.65

1.2

1.3

0.68

0.64

nmol/l

0.22

238

(3025941) Bacteria identified in Stool by Culture

255

1060

2.56

39.35

1.5

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

111

6.17

38.83

1.5

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

14.18

38.24

2.9

2.6

77.22

12.62

mg/l

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

798

2.76

38.19

2.4

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

113

6.06

38.14

1.6

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

105

263

4.12

37.72

1.5

1.3

—

(3020891) Body temperature

212

822

2.72

37.60

8.2

4.4

—

(40758558) Short blood count panel - Blood

810

5267

1.78

37.39

10.9

6.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

221

879

2.65

37.27

2.8

1.8

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

104

261

4.11

37.26

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

103

258

4.11

37.00

1.5

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

197

4.59

36.53

1.3

1619.29

308.17

pmol/l

0.60

166

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

224

4.32

36.06

1.8

1.5

—

(3045142) Bone marrow Pathology biopsy report

238

4.19

35.82

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

417

2213

2.05

35.79

4.6

2.8

8.01

8.07

umol/l

0.02

349

1921

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

161

4.96

35.68

1.8

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

125

5.56

35.40

1.8

1.5

5.59

6.37

u/l

0.16

104

(3029937) Albumin [Presence] in Urine by Test strip

854

5714

1.73

35.24

6.0

3.9

0.00

estimate

1.34

344

1885

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1113

8000

1.68

35.18

5.8

3.8

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

10.41

34.26

5.2

3.5

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

229

4.17

34.18

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

157

548

2.98

33.81

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

290

3.77

33.68

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

228

4.15

33.53

3.6

4.2

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2455

22230

2.59

33.52

40.3

14.3

139.28

139.79

mmol/l

18.82

2427

21602

(3011412) CD3 cells [#/volume] in Blood

186

4.52

33.49

2.3

1.09

1.11

e9/l

0.06

167

(3023103) Potassium [Moles/volume] in Serum or Plasma

2458

22301

2.59

32.84

41.1

14.5

3.98

3.97

mmol/l

1.15

2426

21629

(3025468) Yersinia sp identified in Specimen by Organism specific culture

254

3.93

32.80

1.6

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

254

3.93

32.80

1.6

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

255

3.91

32.62

1.6

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

110

317

3.58

32.38

1.7

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

119

361

3.41

32.38

1.7

1.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

6.00

31.70

1.2

1.1

120.76

79.35

u/l

0.99

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

227

4.02

31.21

1.3

—

nmol/l

—

(3000494) Fungus identified in Specimen by Culture

426

2384

1.94

31.12

1.8

1.4

—

(40768441) Liver Pathology biopsy report

133

5.06

31.05

1.6

1.3

—

(3047181) Lactate [Moles/volume] in Blood

152

550

2.87

30.66

7.1

5.2

1.39

1.22

mmol/l

0.93

139

475

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

6.13

30.65

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

6.13

30.65

1.6

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

803

5454

1.68

30.43

5.5

3.2

—

(3024471) HLA-A [Type]

7.70

29.33

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

148

546

2.81

28.79

2.8

3.62

3.56

g/l

0.17

140

517

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

279

3.57

28.65

1.7

1.4

—

(3024932) HLA-DR beta [Type]

7.65

28.47

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

148

4.62

28.30

1.8

1.2

—

(3008295) Osmolality of Serum or Plasma

141

4.70

28.06

1.5

278.71

284.03

mosm/kgh2o

0.76

100

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

156

600

2.70

28.02

1.8

1.5

0.34

15.62

iu/ml

0.73

117

(40768804) Tissue Pathology biopsy report

1168

8848

1.58

27.65

2.4

2.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

8.28

27.38

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

318

1687

2.01

26.89

2.6

2.1

4.96

7.15

ug/l

2.84

270

1468

(3007566) Smooth muscle Ab [Titer] in Serum

133

484

2.84

26.54

1.2

70.71

105.45

titre

0.92

(3034770) Mitochondria Ab [Titer] in Serum

132

479

2.85

26.48

1.2

1000.00

1118.75

titre

—

(1175426) CD3 cells/100 lymphocytes in Blood

148

4.48

26.45

2.4

2.3

73.25

71.27

0.37

140

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

132

4.71

26.42

1.8

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

100

312

3.29

26.04

1.2

1.4

—

(40761535) Cells panel - Urine sediment

336

1837

1.95

26.01

4.7

3.3

—

(3042631) Mycobacterium sp identified in Specimen

283

3.41

25.90

2.3

2.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

183

4.02

25.40

2.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

183

4.02

25.40

2.2

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

183

4.02

25.40

2.2

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

137

4.53

25.26

2.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

8.95

25.07

4.5

3.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

258

1302

2.09

24.95

1.2

180.04

137.58

iu/ml

0.74

474

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

576

3756

1.68

24.67

5.0

3.4

186.96

670.61

ng/l

1.20

480

2924

(3048689) Calprotectin [Mass/mass] in Stool

401

2365

1.82

24.45

2.3

2.2

140.18

144.27

ug/g

0.10

316

1827

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

101

335

3.10

23.78

2.2

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

101

335

3.10

23.78

2.2

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.23

23.75

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

5.65

23.52

24.5

25.5

95.68

122.68

ug/l

1.81

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

5.36

23.26

3.7

3.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

118

4.65

23.14

1.9

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

123

4.55

22.91

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

119

4.61

22.90

1.9

1.6

—

(3003694) ABO and Rh group [Type] in Blood

783

5593

1.57

22.86

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

236

3.46

22.77

2.1

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

116

426

2.80

22.77

5.1

3.6

61.16

57.47

2.13

116

426

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

318

3.10

22.66

1.3

23.47

43.84

u/l

1.55

275

(3000093) Morphology [Interpretation] in Blood Narrative

172

3.91

22.52

1.2

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

279

3.23

22.35

1.9

2.3

58.83

1580.51

u/ml

0.84

274

(40761536) Microorganisms panel - Urine sediment

324

1838

1.87

22.27

6.2

3.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

125

488

2.64

21.80

3.0

3.3

579.65

898.15

u/ml

0.18

115

452

(3014148) Varicella zoster virus Ab [Titer] in Serum

193

3.64

21.29

1.2

1.1

—

(3011648) Oxygen content in Venous blood

116

4.46

20.82

3.2

3.4

9.97

11.43

1.44

116

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

215

3.42

20.14

2.1

1.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

120

479

2.58

20.02

1.7

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2446

22790

2.06

19.89

40.0

15.0

102.36

76.03

umol/l

49.98

2446

22785

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

108

4.51

19.87

2.6

2.9

38.06

41.14

0.51

(3019977) pH of Arterial blood

5.13

19.78

2.7

3.0

7.42

7.43

0.35

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2234

20267

1.68

19.71

31.7

12.0

70.02

79.46

ml/min/173m2

49.07

2030

16664

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

111

430

2.65

19.68

1.6

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

5.26

19.38

2.4

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.80

19.31

2.3

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

8.40

19.26

1.4

1.5

—

(3004451) EKG impression Narrative

5.19

19.11

1.6

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

312

2.92

19.06

1.4

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

674

4818

1.54

18.99

4.9

3.6

—

(3022145) Colonoscopy Study observation

378

2352

1.71

18.83

1.4

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

223

3.24

18.35

1.1

—

(3004775) Volume in Urine collected for unspecified duration

144

3.81

17.89

3.2

2.2

722.83

629.31

0.80

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

296

1745

1.78

17.79

4.5

2.4

45.63

66.08

ml/min/173m2

15.80

163

678

(3039000) Anion gap in Blood

101

396

2.61

17.50

9.0

5.9

11.63

11.09

mmol/l

0.79

347

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

303

1809

1.76

17.43

3.8

2.4

45.62

66.29

u/l

0.36

263

1546

(3018572) Chloride [Moles/volume] in Blood

101

397

2.61

17.42

9.0

5.9

105.49

105.30

mmol/l

0.13

348

(3009214) Lutropin [Units/volume] in Serum or Plasma

106

427

2.54

17.39

1.6

1.4

14.53

11.53

u/l

0.84

345

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

103

4.33

17.36

2.7

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

103

4.33

17.36

2.7

1.7

—

(3016750) Collection duration of Urine

104

4.29

17.15

3.6

2.0

495.27

480.93

min

0.40

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

504

2.40

17.08

1.9

1.5

358.88

302.10

mu/l

1.01

106

462

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

104

419

2.54

17.06

3.5

2.2

218.75

96.16

ug/min

0.94

244

(36660697) Celiac disease serology panel - Serum

267

1546

1.81

17.02

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

132

3.84

16.81

2.3

2.4

521.69

487.86

e6/l

0.16

111

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

148

3.63

16.45

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

6.33

16.28

1.2

1.3

—

(3026389) Candida sp identified in Specimen by Organism specific culture

273

2.88

16.20

1.9

1.4

—

(40761511) CBC panel - Blood by Automated count

2379

22187

1.77

16.08

32.0

12.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2429

22794

1.87

16.07

20.0

9.9

25.36

25.43

u/l

0.08

2379

21837

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

162

3.45

15.77

1.9

1.4

—

(37021550) Renin [Units/volume] in Plasma --upright

6.63

15.75

1.7

1.3

204.28

46.97

mu/l

0.90

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

153

755

2.09

15.64

2.4

3.5

1316.00

1935.63

u/ml

0.15

133

634

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

38.28

15.38

6.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

276

2.77

14.75

1.1

—

(3017732) Neutrophils [#/volume] in Blood

243

1427

1.77

14.74

3.1

2.9

5.68

4.86

e9/l

0.38

175

1140

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

185

3.18

14.68

1.4

1.2

—

(3044889) 12 lead EKG panel

1714

15034

1.40

14.61

4.8

3.6

—

(3014271) Vancomycin [Susceptibility]

4.30

14.55

3.7

2.7

—

(21494434) Karyotype in Bone marrow

192

3.12

14.45

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

291

2.70

14.40

1.5

1.7

0.99

0.85

g/l

0.19

217

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

114

520

2.25

14.22

2.5

2.8

218.04

184.44

3.04

106

495

(40768795) Lymph node Pathology biopsy report

226

2.92

14.20

1.6

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

420

2.39

14.12

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

420

2.39

14.12

1.3

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

119

555

2.20

14.07

1.9

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

499

3542

1.50

13.99

1.4

1.3

47.78

37.43

iu/ml

0.53

162

1123

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.93

13.99

6.5

5.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.88

13.79

1.6

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

23.90

13.78

1.8

1.5

328.68

303.50

umol/24h

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

328

2127

1.62

13.72

2.0

1.8

1.73

1.45

4.95

270

1873

(3036489) Thrombin time

138

689

2.06

13.69

2.3

21.46

21.34

0.12

127

601

(3002256) Pathology report gross observation

415

2848

1.54

13.60

1.3

—

(3048879) Bone marrow aspiration report

4.81

13.54

1.6

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.46

13.53

1.5

1.2

92.69

207.76

nmol/24h

0.41

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

379

2.42

13.49

1.8

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.13

13.48

2.8

1.8

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

181

3.08

13.24

1.3

1.4

2.77

2.94

g/l

0.21

124

(3024139) IgG subclass 3 [Mass/volume] in Serum

181

3.08

13.24

1.3

1.4

0.56

0.42

g/l

0.40

121

(4062490) Immunoglobulin typing, IgG

181

3.08

13.24

1.3

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

181

3.08

13.24

1.3

1.4

7.32

6.76

g/l

0.32

123

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.15

12.93

1.5

2.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.06

12.83

2.8

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.06

12.83

2.8

1.8

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

370

2.40

12.78

3.2

1.9

1.14

0.76

nmol/l

2.98

307

(3015171) Extractable nuclear Ab [Units/volume] in Serum

148

777

1.96

12.77

1.3

1.2

0.26

1.17

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

9.70

12.71

1.6

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

175

3.07

12.70

1.5

1.7

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

105

488

2.20

12.55

1.3

1.4

465.82

538.37

mg/l

1.17

458

(3016650) Hepatitis A virus Ab [Presence] in Serum

272

2.62

12.44

1.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1414

12186

1.35

12.42

3.3

2.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

5.37

12.29

1.2

434.05

275.42

pmol/l

0.61

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

245

2.70

12.27

1.1

1.74

1.49

g/l

3.47

215

(3020191) Ethanol [Moles/volume] in Serum or Plasma

129

3.37

12.05

1.6

1.3

1.07

1.33

promille

0.45

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

263

1666

1.64

12.04

3.7

2.7

258.76

190.36

ng/l

0.88

237

1513

(3036525) Urea [Moles/time] in 24 hour Urine

26.81

12.04

2.2

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

236

2.71

12.04

1.3

1.4

31.42

28.96

u/l

0.17

196

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

425

2.26

12.02

1.2

1.4

3.92

3.71

mmol/l

0.82

399

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

177

2.98

11.84

1.9

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

468

3383

1.47

11.81

1.3

1.2

9.82

12.87

u/ml

0.54

163

1313

(3044242) Glucose [Moles/volume] in Arterial blood

3.97

11.73

3.0

2.3

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2128

19670

1.43

11.39

8.1

5.3

41.12

39.32

mmol/mol

12.70

1943

17967

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

131

3.24

11.09

1.3

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

102

3.56

11.02

14.2

12.2

0.73

0.64

mmol/l

1.89

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

4.52

10.95

3.3

2.3

1.06

1.64

ug/l

0.63

(3028433) Virus identified in Specimen by Culture

4.03

10.94

1.3

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

119

612

1.99

10.93

1.8

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

321

2.38

10.91

1.8

1.4

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

208

2.73

10.90

2.0

1.5

—

1616.00

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

4.12

10.87

1.3

4.6

5765.25

71.75

mg/l

0.48

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

8.28

10.79

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

10.60

10.76

4.1

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

28.13

10.72

1.2

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

216

2.68

10.69

4.2

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

130

3.19

10.56

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.66

10.52

2.5

2.4

—

(3002385) Erythrocyte distribution width [Ratio]

1982

18183

1.37

10.41

38.1

15.3

15.64

15.09

3.71

1963

17801

(3019150) Specific gravity of Urine by Refractometry

590

4539

1.39

10.38

5.7

4.0

1.02

kg/l

0.94

100

643

(3003434) Protein [Mass/volume] in Pleural fluid

280

2.43

10.29

1.5

1.4

32.61

32.73

g/l

0.03

256

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

122

3.23

10.27

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

133

3.12

10.18

1.1

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

100

496

2.06

10.17

2.1

1.6

14065.25

11830.41

e6/l

0.22

353

(40765096) Chromosome analysis panel by Banding

3.90

10.12

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

192

1176

1.68

10.01

3.1

3.5

60.95

70.11

u/ml

0.21

185

1132

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

10.65

9.77

7.4

4.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

464

2.06

9.70

2.2

2.0

2879.05

2982.22

u/l

0.01

184

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

282

2.37

9.67

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.31

9.63

1.8

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.31

9.63

1.8

2.2

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

102

3.36

9.58

1.1

1.4

5.31

6.49

u/l

0.74

(3049717) Cytology report of Urine Cyto stain

138

781

1.81

9.50

2.3

2.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

204

1288

1.63

9.46

1.7

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.51

9.34

1.5

1.4

1.40

1.10

nmol/l

0.70

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

104

3.30

9.30

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

13.71

9.17

1.2

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

105

3.27

9.17

1.1

1.0

—

(3004616) Nuclear Ab [Presence] in Serum

258

2.40

9.16

1.4

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

234

2.47

9.13

1.8

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

234

2.47

9.13

1.8

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

418

2.07

8.88

1.5

1.6

17.33

15.42

e6/l

0.05

327

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

250

2.39

8.84

1.9

1.6

70.27

57.55

1.69

155

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

419

2.06

8.83

1.6

1.7

402.92

909.49

e6/l

0.56

343

(3044290) Cell count panel - Cerebral spinal fluid

393

2.09

8.78

1.4

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.48

8.64

3.0

3.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.74

8.61

1.0

1.1

1505.77

1516.81

miu/ml

0.02

(3023419) Bacteria identified in Sputum by Culture

304

2.24

8.59

2.7

2.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.81

8.51

1.1

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

105

3.17

8.50

1.1

1.0

0.95

1.13

u/l

1.55

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

100

3.23

8.49

1.2

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

100

3.23

8.49

1.2

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

2469

23765

1.65

8.48

49.0

19.2

38.12

40.06

43.12

2327

22158

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

108

589

1.87

8.40

1.4

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

390

2894

1.41

8.35

12.3

6.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

108

591

1.86

8.32

1.4

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

3.11

8.25

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.53

8.24

2.2

2.3

1389.60

1021.10

u/ml

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.36

8.21

1.2

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

594

1.85

8.19

1.4

1.2

—

(3007461) Platelets [#/volume] in Blood

2469

23785

1.63

8.19

48.8

19.2

254.18

249.96

e9/l

1.96

2436

23123

(3035880) pH of Pleural fluid

113

3.04

8.16

1.4

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

319

2.16

8.06

1.2

—

(3024731) MCV [Entitic volume]

2469

23795

1.63

8.05

48.6

19.1

91.56

91.17

3.55

2449

23382

(3035941) MCH [Entitic mass]

2469

23796

1.62

8.04

48.5

19.1

30.22

30.33

2.15

2449

23380

(3010813) Leukocytes [#/volume] in Blood

2469

23796

1.62

8.04

48.8

19.2

7.20

6.65

e9/l

19.35

2433

23038

(3026361) Erythrocytes [#/volume] in Blood

2469

23798

1.62

8.01

48.7

19.2

4.24

4.48

e12/l

72.82

2434

23053

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.14

7.99

1.0

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

104

571

1.86

7.94

4.7

3.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

2469

23804

1.62

7.92

49.1

19.3

126.81

135.07

g/l

102.13

2449

23391

(3012441) Differential panel - Pleural fluid

201

2.47

7.91

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

251

2.30

7.87

1.5

1.4

1536.69

2290.99

e6/l

0.56

184

(1761482) Bacteria [#/volume] in Urine by Culture

530

1.88

7.85

5.5

4.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.79

7.79

2.7

3.5

215.12

169.37

umol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

174

1109

1.61

7.79

2.7

2.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

5.92

7.67

2.0

1.6

1.19

1.18

mmol/l

0.23

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.52

7.64

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

6.70

7.58

1.4

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.75

7.35

2.5

2.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

107

608

1.79

7.34

1.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2200

20820

1.35

7.24

5.7

4.5

6.14

5.89

mmol/l

11.50

1983

18724

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

6.24

7.23

1.8

1.6

1.24

1.20

mmol/l

0.50

(3017569) Oxygen content in Arterial blood

3.13

7.13

3.1

2.5

—

(4146454) Self-monitoring of blood glucose

197

2.36

6.81

3.3

2.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

181

1206

1.54

6.72

1.3

170.32

199.84

u/ml

0.30

168

1112

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.23

6.69

1.3

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

194

1314

1.51

6.68

2.3

2.1

11.57

12.99

nmol/l

1.37

166

1179

(3046861) Legionella sp Ag [Presence] in Urine

12.27

6.58

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

214

2.27

6.50

1.5

1.6

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

565

1.76

6.44

1.4

1.2

74.90

33.20

u/ml

—

(3001218) Citrate [Mass/time] in 24 hour Urine

+∞

6.25

1.0

0.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

534

1.77

6.21

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

200

2.27

6.15

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

110

2.75

6.11

1.1

10.14

6.73

nmol/l

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

307

2.01

6.10

1.1

25.18

97.79

iu/ml

1.19

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

428

1.85

6.05

1.3

1.2

—

7.99

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.70

6.03

2.0

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

429

1.84

6.01

1.4

1.2

1.06

4.14

u/ml

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.47

6.01

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

196

2.27

5.99

1.8

1.3

118204.77

20626.87

e6/l

0.57

140

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

3.54

5.88

2.3

1.6

5045.00

31435.00

e6/l

—

(3045424) Erythrocytes [Presence] in Urine

368

1.90

5.85

2.0

1.5

—

(3044941) Cell count panel - Synovial fluid

326

1.96

5.84

2.0

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

419

1.84

5.82

3.8

3.2

0.81

nmol/l

0.02

321

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

199

2.23

5.79

1.9

1.4

22.04

32.28

1.37

122

(3051651) Icteric interference index of Serum or Plasma

114

2.65

5.73

5.4

2.5

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.55

5.60

2.0

1.3

17.00

31.37

1.19

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

521

1.73

5.59

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.41

5.58

2.1

2.6

312.22

236.40

e6/l

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

230

2.11

5.50

1.4

11218.90

76768.81

e6/l

1.19

131

(3022621) pH of Urine by Test strip

194

1374

1.44

5.38

4.5

3.0

—

(3045788) Cell count panel - Pleural fluid

200

2.17

5.32

1.3

1.4

—

(3021788) Differential panel - Synovial fluid

382

1.83

5.25

2.0

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

269

1.99

5.22

1.2

2.05

3.66

u/ml

1.74

113

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

138

2.41

5.22

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

138

2.41

5.22

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.65

5.20

1.9

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.35

5.16

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

139

2.39

5.14

1.3

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

2.81

5.14

1.2

119.25

140.31

nmol/l

1.49

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

292

1.94

5.12

3.2

2.2

28.82

25.15

mg/l

0.16

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

13.37

5.08

5.6

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

140

2.37

5.06

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

140

2.37

5.06

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

140

2.37

5.06

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

107

1645

0.64

5.04

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

110

2.56

5.04

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

110

2.56

5.04

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

531

1.68

4.99

1.4

1.2

3.12

4.55

u/ml

0.59

101

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

524

1.68

4.97

1.4

1.2

3.15

2.62

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.67

4.92

1.1

1.2

0.74

0.69

umol/24h

—

(3000034) Microalbumin [Mass/volume] in Urine

161

2.25

4.91

4.2

2.5

228.20

15.57

mg/l

1.37

115

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

235

2.02

4.85

1.1

1.5

0.42

0.28

nmol/l

0.69

177

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

143

2.32

4.85

1.4

17.55

13.02

u/l

1.13

136

(3032057) Clostridioides difficile [Presence] in Stool

3.59

4.76

1.3

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

111

719

1.57

4.75

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

252

1.96

4.69

6.1

5.1

357.34

364.72

umol/l

0.11

216

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1094

0.57

4.68

1.5

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

133

2.35

4.66

1.2

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

355

2832

1.29

4.63

5.2

4.3

32.05

32.70

0.50

263

1847

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

116

2.43

4.55

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

154

2.22

4.53

1.1

1.3

1.70

1.45

nmol/l

0.53

137

(40763480) Human metapneumovirus Ag [Presence] in Specimen

10.03

4.52

1.5

1.0

—

(3000330) Specific gravity of Urine by Test strip

149

1040

1.46

4.50

5.3

3.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

6.69

4.46

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

188

2.09

4.46

1.1

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.94

4.44

1.0

1.1

93.33

85.19

—

(3052592) Norovirus Ag [Presence] in Stool

4.39

4.43

2.4

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

189

2.08

4.40

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.66

4.32

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.05

4.24

1.3

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

193

2.04

4.18

1.3

1.7

—

(4200892) Spirometry reversibility

203

1517

1.37

4.18

1.4

—

(21494755) Public health laboratory ask at order entry panel

112

1636

0.67

4.17

1.2

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

520

1.62

4.13

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.54

4.13

1.3

1.2

—

(40757373) Influenza virus identified in Isolate

3.35

4.04

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

5.57

3.97

1.2

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.54

3.96

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.83

3.95

3.3

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

276

1.83

3.93

1.2

4.27

3.94

u/ml

0.04

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.57

3.88

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.80

3.87

1.3

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.78

3.85

1.0

1.1

108.17

87.61

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

337

1.74

3.85

1.8

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

193

1.98

3.82

3.0

4.2

—

(3028707) Methadone [Presence] in Urine by Screen method

214

1.93

3.82

1.5

1.8

—

(3045414) Leukocytes [Presence] in Urine

134

948

1.44

3.82

2.1

1.8

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

736

6477

1.19

3.79

5.0

5.51

4.34

ug/l

0.45

657

5826

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.77

3.77

1.4

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

504

1.59

3.69

1.3

157.03

221.19

miu/ml

0.80

226

(3026480) Teichoate Ab [Titer] in Serum

5.64

3.65

1.1

—

(3033799) Differential panel - Peritoneal fluid

2.87

3.62

2.2

2.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.41

3.62

2.5

2.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.41

3.62

2.5

2.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

2.75

3.58

2.4

1.9

1632.17

763.82

e6/l

0.32

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.78

3.55

1.0

3.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

105

2.30

3.52

1.9

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

134

965

1.41

3.49

1.4

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

2.77

3.42

1.4

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

186

1418

1.34

3.41

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.84

3.35

2.0

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

106

738

1.45

3.33

1.6

1.4

27.29

30.02

iu/l

0.34

637

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.72

3.32

1.6

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.36

3.31

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

189

1454

1.32

3.26

2.6

2.4

25.45

25.42

au/ml

—

103

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.59

3.26

1.3

1.7

—

(3019174) dRVVT (LA screen)

4.75

3.23

1.3

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.34

3.22

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.80

3.18

9.3

7.7

—

(3006270) Folate [Moles/volume] in Blood

165

1.95

3.14

1.1

385.00

367.84

nmol/l

0.17

144

(3044009) aPTT.lupus sensitive (LA screen)

4.51

3.11

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

105

2.20

3.09

1.7

1.4

2.60

4.70

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.68

3.08

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.68

3.08

1.5

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

125

2.09

3.08

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2085

20086

1.18

3.08

4.8

3.8

1.46

1.25

mmol/l

27.21

1877

18096

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.34

3.01

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

147

1.98

3.00

1.1

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

3.45

2.89

9.4

7.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.60

2.87

1.8

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.60

2.87

2.8

1.7

—

(40758292) HTLV I+II Ab panel - Serum

3.34

2.81

1.6

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

194

1.81

2.80

1.8

2.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.47

2.79

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

166

1.88

2.76

2.2

14.61

7.29

umol/l

0.38

114

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

8.35

2.75

1.8

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.46

2.69

1.7

1.2

—

(3000492) Spirometry study

240

1956

1.25

2.68

1.4

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.76

2.67

12.4

8.1

0.23

0.46

umol/l

—

(3014891) Appearance of Pleural fluid

3.76

2.67

1.0

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.80

2.64

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

267

1.66

2.60

1.1

0.96

2.24

u/ml

—

110

(4212803) Bone marrow aspirate examination

3.61

2.57

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.74

2.54

1.3

1.0

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.87

2.54

1.0

1.1

65.60

79.15

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.87

2.54

1.1

58.00

68.23

—

(3002619) Bacteria identified in Specimen by Culture

2.87

2.54

1.4

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.98

2.48

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.98

2.48

2.9

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.47

2.48

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.47

2.48

1.4

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.47

2.48

1.4

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.82

2.46

1.3

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

2.03

2.46

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

614

5497

1.15

2.43

1.8

1.6

1.53

1.31

mmol/l

5.76

527

4525

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.90

2.41

2.8

2.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.29

2.41

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

138

1.89

2.41

1.2

1.3

—

84.17

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.26

2.37

2.6

4.9

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.42

2.37

1.1

1.3

145.42

521.11

ug/l

—

(3051611) Lipemic interference index of Serum or Plasma

206

1.71

2.34

4.9

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

380

1.51

2.31

1.5

1.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.76

2.27

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.90

2.25

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

334

1.54

2.25

2.2

1.7

196.71

204.93

pmol/l

0.20

317

(3020491) Glucose [Moles/volume] in Blood

149

1.82

2.24

2.3

2.1

6.97

6.66

mmol/l

0.22

(3035320) C reactive protein [Mass/volume] in Body fluid

135

1.86

2.22

3.7

2.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2144

20840

1.16

2.21

5.2

4.2

1.41

1.50

mmol/l

18.68

1953

18951

(3024263) Appearance of Synovial fluid

108

1.95

2.15

1.3

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.01

2.14

1.1

1.2

—

(3016879) Cocaine [Presence] in Urine

454

1.44

2.12

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.46

2.10

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

138

1.82

2.09

1.6

1.3

81.92

78.98

umol/l

0.17

138

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2158

21012

1.15

2.06

5.2

4.2

4.53

4.72

mmol/l

14.18

1975

19217

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

285

1.55

2.06

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

2.18

2.04

1.5

1.3

56.93

55.11

0.06

(40768793) Breast Pathology biopsy report

534

1.40

2.03

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

162

1.74

2.02

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.08

2.01

1.3

1.2

46.38

17.62

u/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

370

3237

1.17

2.00

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

132

1042

1.28

1.99

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

280

1.54

1.98

1.5

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

4.55

1.94

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

322

1.50

1.93

1.8

2.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.19

1.88

1.0

1.2

1.72

1.94

umol/24h

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

3.19

1.88

9.6

7.5

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.94

1.85

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

272

1.52

1.76

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

489

1.38

1.76

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.10

1.76

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.10

1.76

1.1

1.0

—

(3023410) Appearance of Cerebral spinal fluid

185

1.63

1.75

1.3

2.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

185

1.63

1.75

1.8

2.2

3.07

1.91

u/field

0.70

(3038177) Helicobacter pylori Ab [Presence] in Serum

297

1.49

1.75

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2195

21454

1.14

1.75

5.6

4.7

2.63

2.80

mmol/l

15.38

1997

19483

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.30

1.70

4.8

8.0

68.33

72.72

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.96

1.69

1.3

—

(3027008) Opiates [Presence] in Urine

493

1.37

1.69

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

381

0.60

1.67

1.2

1.7

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.0

1.8

—

(3000285) Sodium [Moles/volume] in Blood

2.59

1.66

1.1

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.10

1.65

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

244

1.52

1.65

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.89

1.65

1.1

1.0

—

(3044007) Cell count panel - Peritoneal fluid

2.25

1.63

2.2

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

2.50

1.59

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.70

1.58

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.98

1.54

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.34

1.52

1.0

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

233

1.51

1.52

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.60

1.51

1.0

—

(3028300) Cannabinoids [Presence] in Urine

495

1.34

1.50

1.5

—

(3008898) HLA-B27 [Presence]

647

1.29

1.45

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.13

1.44

1.0

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.73

1.43

1.0

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.04

1.43

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

110

1.73

1.42

1.2

1.1

1.09

1.03

ratio

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.82

1.41

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

279

1.44

1.40

1.3

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.61

1.36

1.3

1.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

1.36

1.0

—

(3027944) Amphetamines [Presence] in Urine

486

1.32

1.36

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.87

1.34

1.6

—

1903858.33

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.97

1.32

2.0

1.4

11.30

8.45

ug/l

1.21

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.97

1.32

2.7

2.8

34.80

29.02

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.09

1.27

1.4

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.27

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.00

1.23

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.00

1.23

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.00

1.23

1.3

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.00

1.23

1.3

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

236

0.59

1.16

1.3

1.4

—

(1761868) Lipid panel - Serum or Plasma

667

7106

0.92

1.15

3.5

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.81

1.15

1.2

1.1

—

(3005033) Fetal Nuchal fold Thickness US

235

0.59

1.14

1.3

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

222

0.58

1.14

1.4

1.6

—

(40768443) Skin Pathology biopsy report

115

964

1.20

1.12

1.3

1.2

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

1.09

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

243

0.62

1.08

1.3

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.89

1.01

1.9

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.62

1.00

2.1

13.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.18

0.98

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.18

0.98

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.72

0.92

1.2

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

143

1.47

0.89

1.6

1.3

0.11

1.45

u/ml

1.40

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

130

0.54

0.87

1.3

1.5

164.07

243.99

pmol/l

—

130

(4034850) Laboratory test

713

1.20

0.87

14.4

9.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.67

0.85

1.0

1.3

0.35

0.29

g/l

1.78

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.94

0.84

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.57

0.84

1.7

2.1

293.60

115.90

ug/min

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.88

0.81

1.7

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

185

0.65

0.75

1.2

—

(3036180) Methadone [Presence] in Urine

1.64

0.73

1.8

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.62

0.71

1.0

1.4

121.64

110.71

0.77

(3006462) Nitrate [Presence] in Urine

109

1.47

0.71

5.4

3.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.85

0.68

1.4

2.4

11.42

17.54

umol/l

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.51

0.66

1.1

9.80

7.56

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.59

0.65

1.1

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.73

0.64

1.0

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

290

0.76

0.61

1.2

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

290

0.76

0.61

1.2

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

312

0.77

0.60

1.3

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

521

0.82

0.60

1.2

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

289

0.76

0.60

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

289

0.76

0.60

1.2

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

198

0.71

0.60

1.2

1.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.60

0.0

2.9

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.60

0.0

5.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.42

0.54

1.2

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

1.39

0.53

1.2

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.54

0.53

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

181

0.72

0.52

1.1

1.5

—

(3003338) MCHC [Mass/volume]

1748

17719

0.96

0.45

41.0

16.9

329.87

332.06

g/l

18.58

1737

17573

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

251

0.80

0.42

1.3

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.56

0.42

1.8

1.7

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.80

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.36

0.41

1.5

1.6

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.40

0.0

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.33

0.40

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

232

1.21

0.40

1.2

1.3

7.56

7.41

mmol/l

0.13

206

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.43

0.39

1.8

1.1

104.60

94.91

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3020650) Glucose [Presence] in Urine

1.34

0.38

1.1

1.7

—

(3014051) Protein [Presence] in Urine by Test strip

548

1.12

0.33

3.4

2.5

—

(40768800) Prostate Pathology biopsy report

417

1.13

0.32

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.33

0.32

3.4

1.8

16.64

116.30

ug/l

0.53

(3001019) Free T4 and TSH panel - Serum or Plasma

942

0.92

0.30

1.9

1.7

—

(3025130) Human papilloma virus identified in Specimen

239

0.84

0.29

1.3

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

151

1597

0.94

0.28

2.2

2.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

669

0.91

0.28

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

657

0.91

0.27

1.4

1.7

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

535

5217

1.03

0.26

4.3

22.28

21.64

0.39

297

2681

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

617

1.09

0.25

1.9

1.7

—

(1617658) Protocol used for examination of sentinel lymph nodes

207

1.16

0.25

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.25

0.24

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

825

0.93

0.22

1.5

1.8

—

(3015183) Erythrocyte sedimentation rate

0.74

0.22

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

312

3215

0.97

0.21

1.4

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

13.6

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

126

1.19

0.21

2.0

1.4

0.99

0.97

g/l

0.07

126

(1002224) Polysomnography panel

731

1.07

0.20

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

442

1.09

0.19

5.9

3.4

30.12

27.00

mg/l

0.20

270

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1652

0.96

0.18

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

727

1.06

0.17

2.0

1.6

3.88

mg/l

0.00

527

(3003888) Timothy IgE Ab [Units/volume] in Serum

289

0.90

0.17

1.1

3.22

4.94

u/ml

0.37

157

(3035933) Granulocytes/100 leukocytes in Blood

1.13

0.17

1.7

1.4

—

(3034426) Prothrombin time (PT)

1.11

0.17

1.1

1.3

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

148

1.15

0.17

1.0

890.45

709.04

ng/l

0.61

(3003740) Influenza virus B Ag [Presence] in Specimen

292

1.10

0.16

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

137

1423

0.96

0.16

2.1

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

217

1.11

0.14

1.1

1.16

3.41

u/ml

1.52

101

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

374

3808

0.98

0.13

3.0

3.1

0.99

0.77

ug/l

1.18

276

2594

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

151

1.13

0.13

1.0

31.33

47.17

ng/l

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

109

0.83

0.13

1.1

1.3

1.69

1.57

g/l

—

109

(4281824) Cell count and differential, peritoneal fluid

229

1.09

0.12

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

212

2169

0.98

0.11

1.5

1.6

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

201

1.10

0.11

1.0

1.1

1.23

5.30

u/ml

—

(44813793) Dust mix specific IgE antibody measurement

135

0.89

0.09

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

279

0.93

0.09

1.1

0.94

1.76

u/ml

—

134

(3002523) Influenza virus A Ag [Presence] in Specimen

291

1.07

0.09

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

268

0.93

0.09

1.0

1.1

2.37

1.55

u/ml

0.19

144

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.80

0.07

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.83

0.07

1.1

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.82

0.07

1.7

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

182

0.93

0.05

1.1

1.0

0.04

0.42

u/ml

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

149

1.07

0.05

1.0

386.80

336.45

ng/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

149

1.07

0.05

1.8

1.6

1.83

5.26

ug/l

1.11

121

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

108

0.93

0.03

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

350

1.03

0.03

1.2

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

132

1.06

0.02

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

626

0.99

0.00

1.3

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

555

0.99

0.00

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

331

1.00

0.00

1.2

1.1

0.59

1.94

u/ml

2.20

180

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

128

1.02

0.00

1.1

1.2

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.94

-0.00

1.8

3.2

7.06

7.74

mg/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.00

-0.00

2.2

1.6

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.38

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_CA_MET – Disorders of calcium metabolism

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Disorders of calcium metabolism

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Disorders of calcium metabolism (E4_CA_MET)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints